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Abstract 
 
Parkinson´s Disease (PD) is the second most prevalent neurodegenerative brain 
disorder worldwide. Nevertheless, there is lack of certainty on the pathophysiology of 
the neurodegenerative mechanisms underlying PD. Several neurotoxins, rotenone 
among them, have been shown to induce parkinsonism-like brain degeneration and are 
widely used in cellular and animal models of PD.    
In spite of an extensive association of PD with dopaminergic neuron 
degeneration of the substantia nigra pars compacta, other brain areas like the 
cerebellum have been more recently implicated in the pathology of the disease. 
Therefore, we used a rotenone/cerebellar granule neurons (CGN) model to study not 
only the potential of creatine (as ergogenic compound), epicatechin and kaempferol (as 
antioxidant compounds) to afford neuroprotection against rotenone neurotoxicity but 
also to better understand the cellular mechanisms underlying this neurotoxicity. 
Our results revealed a strong protection by creatine against rotenone-induced 
CGN death, while kaempferol did not afford a significant protection and epicatechin 
elicited at most a very weak protection. On the contrary, kaempferol also antagonized 
the protective effect of creatine. These results lend support to the potential use of 
creatine in PD therapeutics, and alert for the avoidance of the consumption of foods or 
infusions with high content in kaempferol. 
Furthermore, we noted that rotenone triggered an energetic failure in CGN as a 
primary event, supported not only by the protection afforded by creatine but also by a 
deregulation in calcium homeostasis thought voltage operate calcium channels type L 
and N-Methyl-D-aspartate receptors stimulation and store-operated calcim entry 
inhibition, by the elevation of AMP-kinase active levels and by mitochondrial 
membrane depolarization. Rotenone also promoted an enhanced production of reactive 
oxygen species and a weak nitrosative stress, but only as a later event in the 
development of CGN death.  
In conclusion, our results support a role for creatine in affording neuroprotection 
against rotenone neurotoxicity, through a mechanim that prevent an energetic failure.  
 
Keywords: Parkinson´s disease; cerebellar granule neurons; rotenone; creatine; 
epicatechin; kaempferol; energetic failure. 
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Resumo 
 
A doença de Parkinson é a segunda doença neurodegenerativa mais prevalente a 
nível mundial. Apesar disso, são ainda pouco conhecidos os mecanismos 
neurodegenerativos que estão por detrás desta doença. Varias neurotoxinas, nas quais se 
inclui a rotenona, têm vindo a ser demonstradas como indutoras de degenerescência 
cerebral de tipo-Parkinsonismo e são, por isso, vastamente utilizadas em modelos 
celulares e animais da doença de Parkinson. 
Apesar da extensiva associação entra a doença de Parkinson e a degenerescência 
dos neurónios dopaminérgicos da substantia nigra pars compacta, mais recentemente, 
outras áreas cerebrais, nomeadamente o cerebelo, têm sido implicadas na patogénese da 
doença. Portanto, neste trabalho, foi utilizado um modelo celular de neurónios 
granulares do cerebelo expostos à neurotoxina rotenona. Este modelo foi utilizado, não 
só para estudar a capacidade da creatina (como composto ergogénico) e de epicatequina 
e kaempferol (como antioxidantes) em proteger contra a neurotoxicidade despoletada 
pela rotenona, mas também para melhor entender os mecanismos subjacentes a esta 
neurotoxicidade.  
Os resultados obtidos revelaram que a creatina apresenta uma elevada protecção 
contra a morte celular, induzida pela rotenona nos neurónios granulares do cerebelo, 
enquanto o kaempferol não ofereceu qualquer protecção e a epicatequina, por sua vez, 
promoveu uma protecção demasiado fraca. Pelo contrário, o kaempferol demostrou um 
efeito antagónico relativamente à creatina. Os resultados suportam, assim, o potencial 
uso da creatina na terapêutica da doença de Parkinson e alertam para que se evite o 
consumo de comidas e infusões com um elevado conteúdo em kaempferol nesta mesma 
terapêutica. 
Para além disso, os nossos resultados revelaram que a rotenona como evento 
primário conduz a uma falência energética nos neurónios granulares do cerebelo. Esta 
conclusão é suportada, não só pela protecção exercida pela creatina, mas também pela 
observação de uma desregulação nos níveis citosólicos de cálcio através de uma 
estimulação dos canais de cálcio do tipo L operados por voltagem e dos receptores N-
Metil-D-aspartato e pela inibição da entrada capacitativa de cálcio; pelo aumento dos 
níveis da AMP-quinase activa e ainda pela despolarização da membrana mitocondrial. 
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A rotenona promoveu, por fim, a produção de espécies reactivas de oxigénio e um 
stresse nitrosativo fraco, no decurso da morte dos neurónios granulares do cerebelo.  
Em suma, os resultados suportam a utilização da creatina como composto 
neuroprotector contra a neurotoxicidade exercida pela rotenona, através da prevenção da 
ocorrência de uma falência energética. 
 
Palavras-chave: Doença de Parkinson; neurónios granulares do cerebelo; rotenona; 
creatina; epicatequina; kaempferol; falência energética. 
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1.1. Parkinson´s disease 
 
Parkinson’s disease (PD) is a neurodegenerative disorder characterized, in part, by 
motor disturbances, including tremor, rigidity, bradykinesia, postural instability, and 
rest tremor originating from loss of dopaminergic (DA) neurons of the substantia nigra 
pars compacta (SNc) (Dauer and Przedborski, 2003). In the later stages of the disease 
autonomic and sensorimotor dysfunction, cognitive decline, depression and sleep 
disturbances also occur and become clinically relevant (Marsden, 1990). Non-motor 
functional deﬁcits often precede the major motor symptoms by a number of years and it 
has been suggested that they are indicative of neurodegeneration that originates in the 
brain stem and progresses throughout the brain (Braak et al., 2003). 
PD is the second most prevalent neurodegenerative brain disorder, affecting 1 to 2% 
of the population above 65 years of age and its prevalence increases to approximately 
4% in individuals above 85 years of age (Bekris et al., 2010; de Rijk et al., 2000). 
PD pathology is not restricted to the DA system; degeneration of cholinergic, 
serotinergic, noradrenergic, peptidergic and DA brainstem nuclei, together with the 
presence of proteinaceous intraneuronal inclusions in the soma or dendrites (termed 
Lewy bodies and Lewy neuritis respectively) of neurons in the central, autonomic and 
enteric nervous system (Braak et al., 2003; Braak et al., 2006; Braak et al., 2007; 
Hornykiewicz, 1975; Jellinger, 1991; Klos et al., 2006) have been implicated in 
disease´s pathology. In fact, in the last decades the traditional focus on neurons has been 
changed. Indeed, it is increasingly recognized that degenerating neurons in PD, such as 
DA neurons of the nigrostriatal pathway, do not survive after isolation. These neurons 
receive a variety of afferents and are surrounded by a large number of non-
dopaminergic neurons like GABAergic and cholinergic neurons and non-neuronal cells 
such as astrocytes and microglia. Thus, it is the current belief that the neurodegeneration 
in PD occurs in response to a mixture of deleterious mechanisms taking place both 
inside and outside of degenerating neurons. 
While a fraction of PD occurrence is related to mutations in genes, over 90% of PD 
is sporadic, that is, it occurs in the absence of any obvious genetic linkage. Many 
evidences suggest that there is not much difference between the sporadic and the rare 
familial forms of PD. Specific mutations in nuclear genes encoding α-synuclein (α-syn), 
DJ-1, LRRK2, PINK1, and parkin as well as within the mtDNA were identified in 
familial forms of PD, giving the possibility, by manipulating their expression levels in 
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cellular and animal models, to investigate their physiological function and early 
pathogenic changes that may lead to neurodegeneration  (reviewed in (Cali et al., 
2012)). 
The most significant pathological features of PD are mitochondrial dysfunction, 
oxidative stress (Dexter et al., 1994; Jenner and Olanow, 1998), altered protein 
handling, and inflammatory response (Hirsch et al., 1998; McGeer et al., 1988a; 
McGeer et al., 1988b), which are considered to lead to cell dysfunction and death 
mainly by apoptosis or autophagy (Schapira and Jenner, 2011). 
 
1.1.1. The involvement of cerebellum in PD 
As mentioned before, the pathology of PD is not restricted to DA degeneration.  
Recent studies have implicated other cerebral zones and because of the relevance of this 
work we highlight the cerebellum. 
The cerebellum is a structure located in the posterior fossa of the skull, dorsal to 
the pons and substantia nigra (Figure 1.1). Although the cerebellum accounts for 
approximately 10% of the brain’s volume, it contains over 50% of the total number of 
neurons in the brain (Larsell, 1947). The cerebellum is involved in several functions 
related to movement such as maintenance of balance and posture; coordination of 
voluntary movements; motor learning and in certain cognitive functions, such as 
language. Although motor commands are not initiated in the cerebellum; rather, the 
cerebellum modifies the motor commands of the descending pathways to make 
movements more adaptive and accurate (Knierim, 2012).  
Recently, the application of medical techniques such as transcranial magnetic 
stimulation (TMS), single-photon emission computed tomography (SPECT), positron 
emission tomography (PET) and functional magnetic resonance imaging (fMRI) have 
demonstrated the occurrence of significative alterations in the cerebellum of PD and 
Parkinsonism patients (Brockmann et al., 2012; Cao et al., 2011; Kimura et al., 2011; 
Koch et al., 2009; Ni et al., 2010; Wu et al., 2009a; Wu et al., 2009b).  
Ni et al, (2012) applying TMS in the cerebellum verified decreased excitability 
of the cerebellothalamocortical (CTC) pathway in PD. The authors concluded that the 
CTC pathway is involved in the generation or transmission of postural tremor in PD. 
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Figure 1.1: Schematic representation of specific anatomy areas of the brain.   
 
 
Other authors (Kimura et al., 2011) compared the regional cerebral blood flow 
of patients with different types of Parkinsonism with PD patients and controls. They 
observed a decreased regional cerebral blood flow in the cingulate gyrus and thalamus 
in progressive supranuclear palsy patients, whereas Parkinson variant of multiple 
system atrophy showed decreased regional cerebral blood flow in the cerebellum. These 
findings suggest that parkinsonian disorders show a distinct SPECT pattern in the 
frontal cortex, thalamus, and cerebellum. Therefore these measurements may be helpful 
in screening for the differential diagnosis of parkinsonian syndrome. 
Since resting state brain activity in PD can give clues to the pathophysiology of 
the disorder, Wu et al (2009a) used a regional homogeneity method to investigate PD-
related modulations of neural activity in the resting state. The authors verified a 
decreased regional homogeneity in extensive brain regions, including the putamen, 
thalamus, and supplementary motor area; and increased in some other areas, including 
the cerebellum, primary sensorimotor cortex, and premotor area. Later the same authors 
(Wu et al., 2009b) concluded that PD patients at off-state had significantly decreased 
functional connectivity in the supplementary motor area, left dorsal lateral prefrontal 
cortex and left putamen, and had increased functional connectivity in the left 
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cerebellum, left primary motor cortex, and left parietal cortex compared to normal 
subjects. The authors concluded that a disrupted pattern of functional connectivity of the 
motor network in PD is an important factor contributing to some motor deficits in PD, 
such as akinesia. 
 
1.1.2. Neutoxin models of PD 
The possible involvement of oxidative stress/mitochondrial dysfunction as an 
etiological factor of PD is further supported by studies with specific neurotoxins that are 
extremely potent inducers of Parkinsonism in humans and animals. The best studied of 
these toxins are 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium 
(MPP+), the active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP), which selectively destroys catecholaminergic neurons. Both toxins have been 
shown to generate hydroxyl radicals in the caudate of treated animals (reviewed in 
(Cannon and Greenamyre, 2010)). The rotenone model has also been used to study PD; 
rotenone is a pesticide and a complex I inhibitor, which induces DA cell loss in cell 
culture (Testa et al., 2005) and in animal models (Alam and Schmidt, 2002; Betarbet et 
al., 2000). An inhibition of mitochondrial complex I by rotenone may not only enhance 
reactive oxygen species (ROS) production but also lead to mitochondrial dysfunction, 
such as a decrease in adenosine triphosphate (ATP) production and mitochondrial 
membrane depolarization (Barrientos and Moraes, 1999; Li et al., 2003; Sherer et al., 
2003a). Complex I has been suggested as a strong modulator of the mitochondrial 
permeability transition pore (mPTP), which is responsible for a critical step in the 
mitochondria-dependent apoptotic pathway (Batandier et al., 2004; Chauvin et al., 
2001; Fontaine et al., 1998; Fontaine and Bernardi, 1999). The mPTP is a complex and 
large conductance channel; its opening provokes mitochondrial membrane 
depolarization, release of cytochrome c and sequential activation of caspases that 
eventually lead to apoptotic cell death (Green and Reed, 1998). In addition, rotenone 
can cause PD type neuropathology and movement abnormalities (Hoglinger et al., 2006; 
Sherer et al., 2003a; Sherer et al., 2003b). 
 
1.1.2.1. Cerebellar granule neurons as Parkinsonism model 
The cerebellum is essential for fine motor control of movement and posture, and 
its dysfunction disrupts balance and impairs control of speech, limb and eye 
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movements. The developing cerebellum consists mainly of three types of neuronal cells: 
granule cells in the external germinal layer, Purkinje cells, and neurons of the deep 
nuclei (Figure 1.2). 
 
 
Figure 1.2: Cellular organization of the cerebellar cortex. The cerebellar cortex has only 
three layers. The molecular layer contains two main types of interneurons, the basket (B) and 
stellate (S) cells. The Purkinje cell layer contains the cell bodies of Purkinje cells (PC), whose 
dendrites arborize in the molecular layer; these are the only neurons projecting out of the 
cerebellar cortex. The deepest layer, the granule cell layer, contains the cell bodies of granule 
cells (GC) and other interneurons, such as Golgi cells (Go), Lugaro cells and unipolar brush 
cells (not depicted here). Granule cells are glutamatergic interneurons that extend a single axon 
through the internal granular layer (IGL), and Purkinje cell layer (PCL) that splits into two 
branches, the parallel fibers (PF), in the molecular layer, forming synaptic contacts on Purkinje 
cell dendritic spines. There are two main types of extracerebellar axons projecting to the 
cerebellar cortex: the mossy fibers that contact the granule cells and have several origins in the 
hindbrain and spinal cord, and the climbing fibers that project to Purkinje cells and originate 
from the inferior olivary nucleus in the brainstem (adapted from (Chedotal, 2010)). 
 
  
Granule cells of the cerebellum are the largest homogeneous neuronal 
population of mammalian brain (Chambers and Sprague, 1955a; Chambers and 
Sprague, 1955b; Saab and Willis, 2003). Due to their postnatal generation and the 
feasibility of well characterized primary in vitro cultures, cerebellar granule neurons 
(CGN) are well accepted as a model for the study of cellular and molecular correlates of 
neurodegeneration/neuroprotection (Contestabile, 2002). 
These glutamatergic neurons are extremely sensitive to calcium (Ca
2+
) 
deregulation, in particular mediated by voltage operate Ca
2+
 channel type L (L-VOCC) 
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activity (Franklin and Johnson, 1992; Franklin and Johnson, 1994). The major role in 
maintaining cytosolic Ca
2+
 concentrations within the optimal range for the survival and 
normal excitability of CGN in culture is by Ca
2+
 influx through L-VOCC (Franklin and 
Johnson, 1992; Franklin and Johnson, 1994; Gutierrez-Martin et al., 2005). 
CGN have been widely used as PD model. Rotenone has been shown to induce 
cell death of CGN (Isaev et al., 2004). As little as 5 nM rotenone increased 
mitochondrial superoxide levels and potentiated glutamate-induced cytosolic Ca
2+
 
deregulation, the first irreversible stage of necrotic cell death (Yadava and Nicholls, 
2007). 
Although 6-OHDA is a neurotoxin specific for catecholamine neurons in both 
the central and peripheral nervous systems, cultured rat CGN have been demonstrated to 
be another useful in vitro system for studying the mechanism of 6-OHDA-induced 
neurotoxicity as a PD model. Relatively low concentrations (µM) of 6-OHDA induce 
apoptosis of CGN via activation of a caspase-3-like proteases (Dodel et al., 1999). In 
parallel, 6-OHDA was also demonstrated to produce free radicals in these neurons (Lin 
et al., 2003) as well as enhance excitation of CGN by glutamate (Garber-Goldsman et 
al., 1986). 
On these grounds, CGN have acquired a special position in modern neuroscience 
as one reliable model for the study of neural development, function and, in particular for 
this work, PD pathology. 
 
1.1.3. Cell death in PD 
There are several mechanisms by which cells could die. Until Kerr ﬁrst used the 
term apoptosis (Kerr et al., 1972), all cells were thought to die by necrosis. Necrosis is 
characterized by cytoplasmic swelling, irreversible plasma membrane damage, and 
organelle breakdown (Fiers et al., 1999; Grooten et al., 1993). DNA in necrotic cells is 
usually degraded randomly by extracellular DNAse I present in culture serum that has 
not been heat-inactivated (Napirei et al., 2004), or by lysosomal DNAse II (Tsukada et 
al., 2001), giving rise to a smear of DNA (Higuchi, 2003). The cellular contents leak 
into the extracellular environment, where they may act as a “danger signal”, and 
consequently necrosis is usually associated with inflammation (Proskuryakov et al., 
2003). In addition, there is now sufficient evidence that necrosis, a process traditionally 
regarded as “passive,” may also be genetically programmed. After signalling- or 
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damage-induced lesions, necrosis can include signs of controlled processes such as 
mitochondrial dysfunction, enhanced generation of ROS, ATP depletion, proteolysis by 
calpains and cathepsins, and early plasma membrane rupture. Furthermore, the 
inhibition of specific proteins involved in regulating apoptosis or autophagy can shift 
the type of cell death to necrosis (Festjens et al., 2006; Golstein and Kroemer, 2007). 
For a long time the term “programmed cell death” (PCD) was synonymous of 
apoptosis. Today is known that apoptosis (or Type I cell death) is merely one type of 
PCD. Apoptosis is the major cell death pathway used to remove unwanted and harmful 
cells in a “clean” manner (Ellis et al., 1991), as during apoptosis the membrane integrity 
remains intact with the contents of the dying cell enclosed within apoptotic bodies, 
without releasing them into the extracellular space. DNA in apoptotic cells is degraded 
specifically, giving rise to a characteristic laddering pattern on the gels (Higuchi, 2003; 
Napirei et al., 2004; Tsukada et al., 2001). 
Another type of PCD, autophagic cell death (or Type II cell death), has received a 
signiﬁcant attention from PD researchers in the past few years. Autophagy is recognized 
by the formation of autophagosomes, double membrane autophagic vacuoles that 
eventually fuse with lysosomes to form autolysosomes. Swallowed contents and the 
inner membrane of the autophagosome are subsequently degraded by lysosomal 
hydrolases (Levine and Klionsky, 2004). Various forms of environmental stress induce 
autophagy, which eventually results in either caspase-dependent (Guimaraes et al., 
2003; Xue et al., 1999) or caspase-independent cell death (Gozuacik and Kimchi, 2004; 
Xue et al., 1999; Yanagisawa et al., 2003). 
Nevertheless the same stimulus can trigger multiple cell death pathways, depending 
on its intensity and duration, brain region and cell type, and also depending on the 
bioenergetics state of the cell (Eguchi et al., 1997; Young et al., 2004). All these three 
types of cell death have been identified in PD, predominating apoptosis (Kostrzewa, 
2000)  and autophagy (Anglade et al., 1997; Schapira and Jenner, 2011). 
 
1.2. Brain bioenergetics alterations in PD 
Cellular mechanisms regulating energy utilization must function properly to sustain 
the cell’s life. Dysfunction in mitochondria has been widely associated with PD. 
Therefore, and because mitochondria plays a central role in energy production, 
bioenergetics alterations have been associated with PD.   
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The shortage of mitochondrial supply of ATP and other energy-rich metabolites 
could be counterbalanced by cellular enzymes such as creatine kinase (CK) and 
adenosine monophosphate-protein kinase (AMPK), especially in locations of high 
energy consumption like the cytosol. 
 
1.2.1. Creatine Kinase 
CK is an enzyme that rapidly catalyses the conversion of creatine and consumes 
ATP to produce phosphocreatine (PCr) and adenosine diphosphate (ADP), being an 
important enzyme in producing and buffering energy stores in excitable cells (Schlattner 
et al., 2006).  
In fact, large amounts of energy are required to maintain the signalling activities of 
the cells in the central nervous system. Energy consumption in the brain is largely due  
to the maintenance of brain function-related processes, for example, for maintenance of 
membrane potential by the sodium potassium ATPase (Na
+
/K
+
-ATPase), Ca
2+
 
homeostasis by the Ca
2+
-ATPase, neurotransmitters synthesis, secretion and recycling, 
intracellular signalling, and axonal as well as dendritic transport (Ames, 2000). Indeed, 
it has been proposed that mechanisms to facilitate energy transfer within cells that 
require fluctuating high energy levels, such as brain, include the juxtaposition of 
intracellular sites of ATP generation with sites of ATP consumption, as well as the 
transfer of high-energy phosphates between these sites by the CK/PCr system (Burklen 
et al., 2006). 
The PCr/CK energy pathway represents an extremely efficient energy buffering 
system for two major reasons. First, PCr has a slightly higher diffusion capacity than 
ATP, allowing for a more efficient energy delivery system to different subcellular 
locations. Second, the subcellular localization of cytosolic and mitochondrial CK 
couples areas of high energy consumption with energy production. Thus, the CK/PCr 
essentially serves as a spatial ‘‘energy shuttle’’ or energy circuit within the cell 
(Wallimann et al., 1992). 
There are four isoforms of CK based on its tissue expression (muscle or brain) and 
subcellular distribution (cytosolic or mitochondrial). In the brain, the dimeric cytosolic 
form of CK (CyCK) is called brain-type CK (BB-CK). The octameric mitochondrial CK 
(MtCK) is classified into two forms: sarcomeric muscle form (sMtCK) and brain form 
called ubiquitous MtCK (uMtCK) (Booth and Clark, 1978; Schlattner et al., 2006). Both 
“Creatine Protects Against Rotenone-induced Cell Death of Cerebellar Granule Neurons”          
                                                                                                                    I. Introduction 
 
11 
 
MtCKs are located in the mitochondrial intermembrane space, along the entire inner 
membrane and also at peripheral contact sites where inner and outer membranes are in 
close proximity (Biermans et al., 1990). There, MtCK can directly transphosphorylate 
intramitochondrially produced ATP into PCr (Jacobus, 1985), which is then exported 
into the cytosol (Figure 1.3).  
 
 
Figure 1.3: The creatine kinase/phosphocreatine system. Compartment-specific isoenzymes 
of creatine kinase (CK) are found in mitochondria (sMtCK, uMtCK, left) and cytosol (BB-CK, 
right). They are either associated with ATP-delivering processes (oxidative phosphorylation or 
glycolysis, left) and ATPconsuming processes (ATPases, to maintain local ATP/ADP ratios, 
right), or occur in soluble form (to maintain global cytosolic ATP/ADP ratios, center right). A 
large cytosolic phosphocreatine (PCr) pool of up to 30 mM is built up by CK from creatine (Cr), 
using ATP from oxidative phosphorylation (e.g., in heart) or glycolysis (e.g., in fast-twitch 
glycolytic muscle). The large phosphocreatine pool is then used as a temporal energy buffer to 
maintain constant global and local ATP/ ADP ratios over a wide range of workloads. The higher 
diffusibility of phosphocreatine, as compared to ATP, together with localized CK isoenzymes, 
is used for spatial energy buffering, i.e., for an energy shuttle between ATP-providing or-
consuming processes. The latter seems to be most important for cells that are polarized and/or 
have very high or localized ATP consumption. Adapted from (Schlattner et al., 2006).  
 
 
 
CK isoenzymes are highly susceptible to oxidative stress, an important 
pathophysiological condition associated with the progress of neurodegeneration in PD 
(Schlattner et al., 2006; Wang et al., 2001). In this scenario, MtCK has been suggested 
to be more vulnerable than CyCK due to its mitochondrial localization (Koufen and 
Stark, 2000). In line with this, it has been demonstrated a compromised CK system in 
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common neurodegenerative diseases (Aksenov et al., 2000; Ferrante et al., 2000; Wendt 
et al., 2002). 
 
1.2.1.1. Creatine 
Creatine is a constituent of a normal diet of protein-based foods, such as meat, 
milk, and nuts. It is not considered an essential nutrient, as kidneys, liver, pancreas, and 
possibly brain cells are able to synthesize this compound endogenously from the amino 
acids arginine, glycine, and methionine (Andres et al., 2008; Beard and Braissant, 2010; 
Wyss and Kaddurah-Daouk, 2000). 
The primary physiological function of creatine is to buffer energy concentrations 
in tissues with signiﬁcant and ﬂuctuating energy demands, especially in muscles and 
brain (Wyss and Schulze, 2002). Until recently, the interest in creatine has been largely 
centered primarily on its use as an ergogenic aid to enhance sports performance (Benzi, 
2000; Froiland et al., 2004). Nevertheless, it is becoming increasingly evident that 
administration of creatine might be beneﬁcial in diseases with impaired bioenergetics 
like PD (Andreassen et al., 2001b; Baker and Tarnopolsky, 2003; Bender et al., 2005; 
Bender et al., 2006; Bender et al., 2008a; Brustovetsky et al., 2001; Burklen et al., 2006; 
Shefner et al., 2004).  
Creatine produced dose-dependent neuroprotective effects against MPTP 
toxicity, reducing the loss of dopamine within the striatum and the loss of DA neurons 
in the SNc (Matthews et al., 1999). In addition, it has been shown that creatine may 
stabilize MtCK, and prevent activation of the mPTP (O'Gorman et al., 1997). 
Due to its neuroprotective effects, creatine is now in clinical trials for the 
treatment of PD and Huntington’s disease (HD) (Hersch et al., 2006; NINDS-NET-PD, 
2006). A placebo-controlled randomized pilot trial of creatine supplementation in PD 
showed that creatine improved patient mood and led to a smaller dose increase of 
dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating 
Scale scores or dopamine transporter SPECT (Bender et al., 2006). However, a phase II 
futility trial in PD showed approximately a 50% improvement in Unified Parkinson’s 
Disease Rating  Scale at one year, and the compound was judged to be non futile. Due 
to this ﬁnding, creatine is now under further investigation in a phase III clinical trial by 
the NET-PD investigators (NINDS-NET-PD, 2006).  
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More recently, oral creatine supplementation showed to attenuate levodopa (L-
DOPA)-induced dyskinesia, a motor complication that arises in Parkinson patients after 
a chronic treatment with L-DOPA, in 6-OHDA-lesioned rats (Valastro et al., 2009). 
However, the molecular mechanisms underlying the neuroprotective actions of creatine 
are under current scientific debate. For example, stimulation by creatine of hippocampal 
Na
+
,K
+
-ATPase activity via N-Methyl-D-aspartate (NMDA)–calcineurin pathway is a 
very recent novel finding (Rambo et al., 2012), suggesting that the role of creatine in 
neuronal bioenergetics modulation can be more complex than currently assumed. 
The safety of creatine supplementation has been reviewed extensively, and it has 
been concluded that creatine supplementation does not have any deleterious effects in 
humans (Bender et al., 2008b; Hersch et al., 2006; Mihic et al., 2000). These evidences 
clearly show the potential of creatine in PD’s therapy and in other neurological diseases.  
 
1.2.2. AMP-Kinase 
 AMPK is a heterotrimeric complex of a catalytic subunit (α) and two regulatory 
subunits (β and γ). AMPK is activated by phosphorylation of the α subunit at Thr172 
(Hawley et al., 1996), being the downstream component of a protein kinase cascade. 
Once activated, AMPK switches-on catabolic pathways that generate ATP, while 
switching-off energy-consuming anabolic processes, thereby, acting as a key cellular 
modulator for the maintenance of the energy balance within cells. AMPK activation has 
been demonstrated to be regulated not only by cellular AMP/ATP ratio, but also by Ca
2+
 
concentration and ROS (Hawley et al., 2005; Jung et al., 2008; Park et al., 2006; 
Weekes et al., 1994). When activated, AMPK phosphorylates several intracellular 
protein targets, like acetyl-CoA carboxylase, nitric oxide synthase and peroxisome 
proliferator-activated receptor gamma coactivator-1-α (Chen et al., 2000; Fryer et al., 
2000; Suwa et al., 2003). 
It has been reported that AMP-activated protein kinase is also activated by MPTP 
and other investigators have shown that overexpression of AMPK increased cell 
viability (Choi et al., 2010; Culmsee et al., 2001). These and other studies suggest that 
activation of AMPK may prevent neuronal cell death in neurodegenerative disease like 
PD. This possibility is also supported by recently published experimental data. Wu et al 
(2011) have demonstrated that AMPK and/ or mammalian silent information regulator 2 
are required in resveratrol mediated autophagy induction, leading to neuronal survival 
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on PD cellular models. On the other hand, Arsikin et al (2012) have demonstrated that 
the neurotoxin 6-OHDA induces cytotoxic autophagy in SH-SY5Y neuroblastoma cells 
through the oxidative stress-dependent activation of AMPK and subsequent inhibition 
of the main autophagy repressor mTOR. Thus, these studies reveal that depending on 
the cellular insult the activation of AMPK can play either a neuroprotector or neurotoxic 
role.  
 
1.3. Oxidative stress in the brain 
The imbalance between normal cellular and environmental-induced production 
of ROS and reactive nitrogen species (RNS) and the ability of cells to efficiently defend 
against them (by the natural antioxidant defence system) is called oxidative stress. 
Oxidative stress produced in the body is toxic, could damage DNA, lipids and proteins 
leading to necrosis, ATP depletion, and prevention of controlled apoptotic death (Beal, 
2005). 
Since the brain uses 20% of the inspired oxygen and 80-90% of the consumed 
oxygen to produce energy during oxidative phosphorylation and the cefaloraquid liquid 
has lower antioxidant potency than the blood plasma, it is not surprising that neuronal 
cells are particularly sensitive to oxidative stress. During oxidative phosphorylation, 
neurons in the brain are extremely vulnerable to oxidative damage because of their high 
metabolic activity, low antioxidant capacity (Nunomura et al., 2006), non-replicative 
nature and the presence of high levels of polyunsaturated fatty acids which are readily 
oxidized (Perry et al., 2002). Additional chalenge is the presence of the blood-brain 
barrier, which protects the brain from toxins by limiting their diﬀusion into neurons and 
glia but also prevents/reduces the uptake of some blood-circulating antioxidants like 
vitamin E, into the brain. In this regard, it is to be noted that neurons may be exposed to 
ROS/RNS produced intracellularly and extracellularly, respectively, by neuronal cells 
and non-neuronal cells, such as microglia and endothelial cells of blood vessels.  
 
1.3.1. Oxidative stress in PD  
The etiology of PD is unknown although mitochondrial dysfunction, oxidative 
and nitrosative stress have been implicated in the mechanisms associated with PD 
pathogenesis (Danielson and Andersen, 2008; Dawson and Dawson, 2003; Fahn and 
Cohen, 1992; Fiskum et al., 2003; Hashimoto et al., 2003; Jenner, 2003; Kanthasamy et 
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al., 2010; Tsang and Chung, 2009). However, it is not clear whether oxidative stress is a 
consequence of dysfunctional and dying neurons or plays a causal role in this 
neurodegenerative disease. 
Postmortem tissues from PD patients have provided experimental evidences 
supporting that a deficient function of complex I of the mitochondrial electron-transport 
chain in SNc, i.e. 30–40% decrease in its activity, may be one of the central causes of 
sporadic PD (Dawson and Dawson, 2003). The decreased activity could be due to 
underproduction of certain complex I subunits, complex I disassembly, or self-damage 
by ROS produced during its function (Beal, 2004; Keeney et al., 2006; Schapira, 2001).  
More evidences of oxidative stress and PD come from examination of human 
PD brain showing oxidative damage to DNA and protein (protein carbonyls) besides 
immunocytochemical evidences for oxidative modifications of proteins by nitration, 
nitrosylation and glycation (Alam et al., 1997; Beal, 2002; Brown and Borutaite, 2004; 
Castellani et al., 1996; Floor and Wetzel, 1998; Good et al., 1998; Kikuchi et al., 2002; 
Zhang et al., 1999), and also by increased levels of lipid peroxidation (Dalfo et al., 
2005). Along with the increase in oxidative damage, decreased levels of the antioxidant 
glutathione (GSH) were also found in the SNc of PD patients (Pearce et al., 1997; Perry 
et al., 1982; Perry and Yong, 1986).  
 
1.3.1.1. Flavonoids in PD:  Kaempferol and Epicatechin 
In the last decade flavonoids have been described as important neuroprotectors 
against PD (Gagne et al., 2003; Pan et al., 2003; Panickar et al., 2009; Tan et al., 2008; 
Vauzour et al., 2010). This neuroprotection has been mainly attributed to their 
antioxidant and anti-inflammatory capacities (Aquilano et al., 2008; Dajas et al., 2003; 
Gutierrez-Merino et al., 2011). In the present study, taking into account the 
experimental data pointing out the occurrence of oxidative stress in the brain of patients 
with PD, we have studied the ability of the flavonoids kaempferol and epicatechin to 
afford protection against rotenone-induced neuronal death. 
Kaempferol is a natural flavonoid that exists in propolis (Scheller et al., 1990), 
tea (Tsaknis and Lalas, 2005), Gingko biloba (Smith and Luo, 2003) and other plant 
sources, which have been considered as a potent antioxidant and anti-inflammatory 
compound (Comalada et al., 2006; Martini et al., 2004; Wang et al., 2006). Ginkgo 
biloba extracts, quercetin and kaempferol have been reported to rescue PC12 cells 
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exposed to MPP+-induced oxidative stress and also to reverse neurotoxin effect (Gagne 
et al., 2003). More recently, the neuroprotective effect of kaempferol against MPTP was 
confirmed in a mouse model (Li and Pu, 2011). Kaempferol derivatives have also been 
recognized with protective potential in PD; they have been shown to prevent oxidative 
stress–induced cell death in a genetic (DJ-1)–dependent manner (Qu et al., 2009). Very 
recently, kaempferol was implicated in the enhancement of mitochondrial turnover by 
autophagy, revealing to be antiapoptotic and antioxidant in rotenone models of PD 
(Filomeni et al., 2012).  
 Epicatechin is a catechin present in cocoa (Dreosti, 2000; Sanchez-Rabaneda et 
al., 2003), green tea (Graham, 1992) and red wine (Damianaki et al., 2000). This 
flavonoid has been widely demonstrated to act as a cellular antioxidant, free radical 
scavenger and iron chelating (Lee et al., 2003; Pan et al., 2003; Xu et al., 2004), being 
neuroprotector in PD, not only by itself but also as a constituent of the mentioned 
sources of polyphenols (Datla et al., 2007; Gao et al., 2012; Levites et al., 2001). For 
instance, green tea polyphenols have demonstrated to elicit neuroprotection in cell 
cultures and animal models, such as the prevention of neurotoxin-induced 
neurodegeneration of the striatum and DA neurons of the SNc (Panickar et al., 2009). 
Recently, Vauzour et al. (2010) have reported that the flavonoids catechin, epicatechin 
and quercetin and polyphenols like caffeic acid and p-coumaric acid afford protection 
against the neurotoxicity of 5-S-cysteinyl-dopamine, which has been proposed to 
contribute to the progression of the brain neurodegeneration in PD.  
 
1.4. Calcium homeostasis in brain 
Intracellular Ca
2+
 regulates a wide array of cellular processes and is important 
for signal transduction. Many biological processes of great importance for the neuronal 
function are extremely dependent on cytosolic Ca
2+
 concentration, such as secretion of 
neurotransmitters and synaptic plasticity (Trifaro and Vitale, 1993), intracellular 
signaling pathways that mediate the metabolic extracellular neuronal stimuli (Berridge 
et al., 2000) and development of neurites (Benowitz and Routtenberg, 1997). Ca
2+
 plays 
a central role not only in normal and healthy neurons but is also involved in the many 
cellular processes (e.g. oxidative stress, mitochondrial impairment, proteasomal 
dysfunction, excitotoxicity, neuroinflammation, apoptosis) that can lead to cell death in 
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PD (Berridge et al., 2000; Bueler, 2010; Hegde and Upadhya, 2011; Lau and 
Tymianski, 2010; Witte et al., 2010). 
The concentration of cytosolic free Ca
2+
 in resting neurons (≈100 nM) is 10,000 
fold lower than the concentration of Ca
2+
 in the extracellular space (≈1.2 mM) 
(Gleichmann and Mattson, 2011). This concentration gradient leads to a signiﬁcant 
increase in cytosolic Ca
2+
 after depolarization, rendering Ca
2+
 regulation a critical 
process in neurons. To maintain Ca
2+
 homeostasis, Ca
2+
 entering neurons is rapidly 
sequestered in intracellular organelles, such as the mitochondria and the endoplasmic 
reticulum (ER), or pumped back across the plasma membrane concentration gradient, 
all of which require the consumption of high levels of energy in the form of ATP 
(Gleichmann and Mattson, 2011). In neurons the Ca
2+
 transport systems of the plasma 
membrane most important in the control of the homeostasis of cytosolic Ca
2+
 are 
voltage-operated calcium channels (VOCC), some ionotropic receptors (with the 
NMDA receptors playing an outstanding role in the brain), the plasma membrane Ca
2+
 
ATPase (PMCA) and the Na
+
/Ca
2+ 
exchanger (NCX) (Gutierrez-Merino, 2008). Ca
2+
 
influx through L-VOCC has a major role in maintaining cytosolic Ca
2+
 concentrations 
within the optimal range 70 to 200 nM for the survival and normal excitability of CGN 
in culture (Gutierrez-Martin et al., 2005).  
The sustained impairment of intracellular Ca
2+
 homeostasis in neurons 
associated with the oxidative stress induced by an elevated production of ROS is a 
common metabolic feature in brain neurodegenerative diseases. Moreover, cytosolic 
Ca
2+
 concentration can be regarded as a major bioenergetic marker for neuronal activity 
and neuronal survival, as it has been shown that a sustained low cytosolic Ca
2+
 
concentration elicits apoptosis in neurons in culture (Franklin and Johnson, 1992; 
Franklin and Johnson, 1994), and also that a steadily elevated cytosolic Ca
2+
 
concentration induces rapid cell death by necrosis mediated by activation of calpains 
(Choi, 1988; Franklin and Johnson, 1992; Garcia-Bereguiain et al., 2008; Gutierrez-
Martin et al., 2005; Orrenius et al., 1989). 
 
1.4.1. Alterations of calcium homeostasis in PD 
In spite of the occurrence of degeneration in other brain areas, DA region is one 
of the most affect in PD patients. Many characteristics of DA neurons have been point 
out that these are neurons with high energy requirements (Surmeier et al., 2011a). 
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Unlike the vast majority of neurons in the brain, adult SNc DA neurons are 
autonomously active, generating broad slow action potentials regularly (2–4 Hz) in the 
absence of synaptic input (Grace and Bunney, 1983). This pacemaking activity is 
believed to be important in maintaining ambient DA levels in regions that are 
innervated by these neurons, particularly the striatum (Romo and Schultz, 1990). 
Whereas the majority of neurons rely exclusively on monovalent cation channels (like 
sodium (Na
+
)) to drive pacemaking, SNc DA neurons also express ion channels that 
allow extracellular Ca
2+
 to enter the cytoplasm (Ping and Shepard, 1996; Puopolo et al., 
2007), which lead to elevated intracellular Ca
2+
 concentrations (Chan et al., 2007; 
Wilson and Callaway, 2000). The use of Ca
2+
 rather than Na
+
 ions for pacemaking 
involves more energy costs for neurons in order to maintain a safe intracellular Ca
2+
. 
The Ca
2+
 channels involved in this pacemaking activity have a distinctive Cav1.3 pore-
forming subunit (Chan et al., 2007). Cav1.3 Ca
2+ 
channels are relatively rare (Sinnegger-
Brauns et al., 2009), but they are found at an extraordinary high density in SNc DA 
neurons (Guzman et al., 2009; Khaliq and Bean, 2010; Puopolo et al., 2007). 
It is now accepted that Ca
2+
 entry through plasma membrane Cav1.3 Ca
2+
 
channels during activity is either pumped back across the plasma membrane (by PMCA 
and/or NCX) or rapidly sequestered in the ER or mitochondria (Surmeier et al., 2011a) 
(Figure 1.4). Both processes waste cellular energy stored in the form of ATP. The 
metabolic demand created by these ATP-dependent steps in Ca
2+
 homeostasis should 
increase oxidative phosphorylation in mitochondria and the production of damaging 
ROS (Guzman et al., 2010). This places SNc DA neurons in a stressful working 
situation, as ROS damage mitochondrial proteins such as complex I and mtDNA, 
reducing the efficiency of oxidative phosphorylation (Harman, 1972; Wallace, 2005). In 
extreme cases, the stress on mitochondria induces mPTP opening, swelling and the 
release of cytochrome c and other pro-apoptotic proteins such as apoptosis inducing 
factor (Nicholls, 2002). In parallel, ROS are capable of damaging ER proteins, elevating 
the concentration of misfolded proteins that need to be degraded by proteasomes and 
autophagosomes (Kaufman, 1999). The unfolded protein response triggered by this 
elevation in misfolded proteins should further reduce ER production of proteins and 
potentially lead to the release of pro-apoptotic factors such as C/EBP homologous 
protein (CHOP) (Chan et al., 2009; Oyadomari and Mori, 2004). The role of 
mitochondria in Ca
2+
 homeostasis could further compromise their ability to generate 
ATP, leading to a functionally important drop in cytosolic ATP levels (Nicholls, 2002). 
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Figure 1.4: Ca
2+
 transport in SNc DA neurons. The steep concentration gradient for Ca
2+
 
enables it to cross the plasma membrane readily into cells through open pores such as L-type 
Ca
2+
 channels (Cav1.3 VOCC-subtype). Once inside neurons, it is either transported back across 
the plasma membrane (by PMCA or NCX) or sequestered in intracellular organelles (i.e. 
mitochondria and ER). The ER uses high-affinity smooth ER Ca
2+
 (SERCA) pumps that depend 
upon ATP to take Ca
2+
 from the cytoplasm into the ER lumen. Ca
2+
 flows back into the 
cytoplasm after the opening of inositol trisphosphate receptors (IP3R) and ryanodine receptors 
(RyR) also located in the ER membrane. Mitochondria are often found in close apposition to the 
ER and plasma membrane, creating a region of high (but localized) Ca
2+
 concentration that 
drives Ca
2+
 into the matrix of mitochondria through a Ca
2+
 uniporter. Ca
2+
 can leave the 
mitochondrion through a number of mechanisms. The dominant mitochondrial Ca
2+
-efflux 
pathway in neurons is through mitochondrial NCXs. Ca
2+
 release through higher conductance 
ion channels, such as the mitochondrial permeability transition pore (mPTP), has also been 
proposed. The mPTP is known to have two conductance states: a low-conductance state that is 
reversible and participates in physiological Ca
2+
 handling, and a high conductance state that is 
irreversible and leads to mitochondrial swelling and loss of molecules such as cytochrome c that 
trigger apoptosis (adapted from (Chan et al., 2009)). 
 
 
 
Genetic mutations or environmental toxins such as rotenone could further 
compromise mitochondrial or ER function, rendering them more vulnerable to Ca
2+
 
stress (Surmeier et al., 2011b). By rushing the decline in ER and mitochondrial function 
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and the accelerated loss of SNc DA neurons, these genetic and environmental factors 
could be seen as “causing” PD. 
 
1.5. Aims 
The major aim of this work was to assess the potential of the ergogenic molecule 
creatine and the flavonoids epicatechin and kaempferol (and possible synergism 
between these compounds) to afford neuroprotection of CGN in culture against 
rotenone, a toxin used to induce parkinsonism-like neurodegeneration. 
 Due to its energetic capacity, creatine has been shown to be a neuroprotector in 
some neurodegenerative diseases such as HD and PD, being at the time in phase III 
clinical trials (Hersch et al., 2006; NINDS-NET-PD, 2006). Moreover, we wanted to 
evaluate the benefits/inconveniences of co-administration of creatine with flavonoids 
like kaempferol and epicatechin that have been proposed to be bioactive compounds 
accounting, at least in part, for the beneficial effects of green tea against the progress of 
neurodegeneration in PD treatment. 
In addition, as the cellular mechanisms underlying the neurotoxicity exerted by 
rotenone in CGN are not well understood, a second major goal of this work is to use 
creatine and the above mentioned flavonoids as tools to shed light on the relative 
relevance of the different mechanisms proposed to mediate brain neurodegeneration in 
PD.    
To achieve these major goals, we have defined the experimental strategy and 
partial objectives schematically presented in figure 1.5. 
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Figure1.5: Schematic representation of the experimental strategy and partial objectives of 
this research work. 
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2.1. Equipment and reagents 
 
2.1.1. Scientific equipment 
 Laminar Flow Cabinet Nüve LN 090 
 CO2 incubator Heal Force - HF 90 
 Microcentrifuge Eppendorf 5415R 
 Ultracentrifuge Beckman Coulter Optima™ L-90K 
 Spectrophotometer PG Intruments T70 
 Fluorescence Spectrophotometer Perkin Elmer 650-40 
 Varioskan Flash spectral scanning multimode reader Thermo Scientific 
 Epifluorescence microscope Nikon Diaphot 300 
 Microscope camera Hamamatsu ORCA-R2 
 Microscope Wheel Filters Lambda 10-2  
 Electrophoresis system and western blotting BIO-RAD 
 
2.1.2. Chemicals and reagents 
All antibodies were used at a dilution in the range 
recommended in the product datasheets. The primary antibodies used are described in 
Table 2.1, and the secondary antibodies labeled with fluorophores are described in 
Table 2.2. 
Western blotting reagents anti-goat IgG horseradish peroxidase anti-rabbit IgG 
horseradish peroxidase and SuperSignal West Dura Extended Duration Substrate were 
purchased from Pierce (Rockford, IL, USA).  
All other reagents and chemicals were supplied by Sigma-Aldrich, Roche or 
Merck (Darmstadt, Germany). 
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Table 2.1- Informative description of the primary antibodies used in Western blot 
experiments. 
Antibody Produced in: Trading house Reference 
Caspase-3 Rabbit Calbiochem PC679 
Nitrotyrosines  Mouse Calbiochem-Merck KGaA CC22.8C7.3 
Creatine Kinase-B  Goat Santa Cruz Biotechnology sc-15157 
Phospho-AMPKα Rabbit Cell Signaling 
Technology® 
2535 
Cathepsin D Goat Santa Cruz Biotechnology sc-6494 
 
Table 2.2- Informative description of the secondary antibodies used in Western blot 
experiments. 
Antibody Trading house Reference 
anti-Rabbit IgG-Alexa488  Invitrogen  
(Molecular Probes, Eugene, OR, USA) 
A11008 
anti-Goat IgG-Alexa488 Invitrogen  
(Molecular Probes, Eugene, OR, USA) 
A11055  
anti-Mouse IgG-Alexa488  Invitrogen  
(Molecular Probes, Eugene, OR, USA)  
A11001 
 
2.2. Buffers and solutions 
The composition of MLocke 25 buffer (pH 7.4 at 37° C) used in all experimental 
work with cerebellar granule cells is: 4 mM NaHCO3, 10 mM N-[tris (hidroxymetil) 
metil] glicine, 5 mM glucose, 2.3 mM CaCl2, 1 mM MgCl2, 134mM NaCl and 25 mM 
KCl.  
The composition of sample buffer used for SDS-PAGE in this work is 26.6 mM 
Tris-HCl pH 6.8, 0.86% sodium dodecyl sulfate (SDS), 0.43% (v/v) β-mercaptoethanol, 
0.014% bromophenol blue prepared in 20 mM Tris pH 7 and 37.3% glycerol. 
The composition of the electrophoresis buffer used for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) throughout the experimental work is: 
25 mM Tris, 190 mM Glycine, 10% SDS (pH 8.3). 
The transfer buffer composition used in Western blotting 
in all this work is: 25 mM Tris, 190 mM Glycine, 0.1% SDS, 20% methanol (pH 8.3).  
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The composition of phosphate buffered saline (PBS) is 4.3 mM Na, 0.4 mM 
KH2PO4, 137 mM NaCl and 27 mM KCl (pH 7). 
 
2.3. Biological Material 
Cultures of cerebellar granule cells were prepared from 7 days old Wistar rats, 
weighing 20-25 g. The rats were supplied and maintained by the Animal Service of the 
University of Extremadura, where they have been fed and maintained at a constant 
temperature of 22-23 ⁰ C and humidity ranging between 60 and 80 %. 
 
2.4. Cell cultures 
2.4.1. Cerebellar granule cells primary cultures 
Cultures of CGN were obtained from dissociated cerebella of 7 day old Wistar rats 
as described previously (Samhan-Arias et al., 2004). Cells were plated in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% heat inactivated fetal 
bovine serum (FBS), 5 mM glucose, 19.63 mM KCl, 3.7 ng/mL insulin, 7 µM para-
aminobenzoic acid, 50 U/mL penicillin, 25 U/mL streptomycin, 0.91 mM pyruvate and 
2 mM L-glutamine on 35 mm dishes coated with poly-D-lysine, at a density of 2.75x10
6
 
cells/dish. Cultures were maintained at 37ºC in a humidified atmosphere of 95 % air/5 
% CO2. Cytosine arabinofuranoside (10 µM) was added to fresh culture medium 48 h 
after plating to prevent replication of nonneuronal cells. The culture medium was 
replaced with serum-free medium 7 days after plating. Cells were maintained afterward 
in serum-free F12 medium supplemented with 12.5 mM glucose, 20.82 mM KCl, 5 
µg/ml insulin, 0.1 mg/ml apo-transferrin, 20 nM progesterone, 50 U/ml penicillin, 25 
U/ml streptomycin, 0.1 mg/ml pyruvate, 2 mM L-glutamine. All experiments were 
performed using mature CGN at 9–10 days in vitro (DIV). 
 
2.5. Viability assays 
2.5.1. MTT  assay 
Neuronal viability was assessed by the 3-(4,5-dimethyl-thiazole-2yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction test as described in (Martin-Romero et 
al., 1996; Samhan-Arias et al., 2004). Viable cells reduce MTT to formazan which can 
be determined spectrophotometrically. In brief, the culture medium was replaced with 2 
mL of MLocke 25 buffer and incubated for 15 min with 0.3 mg MTT. Thereafter, 
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formazan was dissolved in 1 mL of dimethyl sulfoxide (DMSO) and measured at 490 
nm and 700 nm. 
 
2.5.2. Treatment of CGN with Rotenone 
To investigate the effect of rotenone on CGN viability, the treatment was 
performed at 9 DIV in CGN. To this end, the plates containing the CGN were incubated 
for 12 hours at 37 ⁰ C with 0, 2, 5, 10, 15, 20, 30 and 50 nM of Rotenone prepared in 
DMSO. After the incubation period the plates were subjected to MTT assay described 
in section 2.5.1. 
 
2.5.3. Treatment of CGN with 6-OHDA 
To investigate the effect of 6-OHDA on CGN viability, cells at 9 DIV were 
incubated for 24 hours at 37 ⁰ C with 0, 5, 10, 15, 20, 25, 30 and 50 µM of 6-OHDA 
prepared in DMSO. After the incubation period the viability was evaluated by MTT 
assay described in section 2.5.1. 
 
2.5.4. Flavonoids protection against rotenone-induced cell death in CGN 
To investigate the protective effect of the flavonoids: kaempferol and 
epicatechin, cells at 9 DIV were incubated for 1 hour with 0, 2, 5 and 10 µM of each. 
Thereafter, rotenone (IC50 concentration) was added to the culture medium and 
incubated for 12 hours. After the incubation period the cell viability was evaluated by 
MTT assay described in section 2.5.1. 
 
2.5.5. Creatine protection against rotenone-induced cell death  in CGN 
To investigate the protective effect of creatine, cells at 9 DIV were incubated for 
1 hour with 0, 5, 10, 15, 20 and 30 mM. Thereafter, rotenone (IC50 concentration) was 
added to the culture medium and incubated for 12 hours. After the incubation period the 
viability was evaluated by MTT assay described in section 2.5.1. 
 
2.6. Protein quantification and determination 
2.6.1. Preparation of cell lysates 
CGN cultured for 9 DIV were washed with buffer MLocke 25. Then, the CGN 
were resuspended and centrifuged at 4 ° C for 2 min at 2000g in a refrigerated 
“Creatine Protects Against Rotenone-induced Cell Death of Cerebellar Granule Neurons”          
                                                                                                  II. Material and Methods               
 
28 
 
Eppendorf microcentrifuge, pellets of lysed cells were re-suspended in 100 µL of buffer 
(50 mM HEPES, pH 7.4, 100 mM NaCl , 0.1% CHAPS, 1 mM DTT and 0.1 mM 
EDTA) for colorimetric measurements and in 200 µL of buffer (5 mM NaP, pH 7, 1 
mM EDTA, 0.5% Tween 20 supplemented with protease inhibitor cocktail Roche 
Biochemicals (COMPLETE)) for Western blotting. 
 
2.6.2. Protein concentration 
Protein concentration was determined by the method of Bradford (1976) using 
the Bio-Rad (Hercules, CA, USA) protein assay reagent and bovine serum albumin as 
standard.  
 
2.6.3. Western blotting 
SDS-PAGE were run at a concentration of 15%, 12.5% and 7.5% acrylamide, 
depending on the molecular weight of the protein of interest, using 20 µg protein of 
CGN lysates per lane. Gels were transferred to nitrocellulose membranes of 0.2 µm or 
0.4 µm average pore size (TransBloTTransfer Medium, BioRad). Nitrocellulose 
membranes were blocked by 1 h incubation at room temperature with 5% (w/v) non-fat 
dry milk in PBS. Then, nitrocellulose membranes were washed three times with PBST, 
e.g. PBS supplemented with 0.05% polyoxyethylenesorbitan monolaurate (Tween 20). 
Immunodetection of proteins was performed with its specific antibody at recommended 
dilutions. After incubation with the first antibody overnight, membranes were washed 
six times with PBST and incubated for 1 h at room temperature with the secondary 
antibody IgG conjugated with horseradish peroxidase (anti-rabbit, anti-mouse and anti-
goat with a dilution of 1:8.000, 1:50.000 and 1:500.000, respectively), then washed six 
times with PBST, followed by incubation for 3 min with SuperSignal West Dura 
Substrate (Pierce). Western blots were revealed by exposure to an AmershamHyperfilm 
MPautoradiography film (GE Healthcare, UK). 
 
2.7. Cell death pathways 
2.7.1. Caspase-3 and Cathepsin D activation  
Caspase-3 and cathepsin D activations were investigated by Western blotting 
after SDS-PAGE of lysates as described in 2.6.3. To detect caspase-3 was used a 
polyclonal rabbit anti-activated caspase-3 antibody (1:200; Calbiochem PC679) against 
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the 17 kDa cleaved (active) fragment of caspase-3. For positive control, activated 
recombinant human caspase-3 (Calbiochem) was also loaded to the gels. Cathepsin D 
was revealed using a goat polyclonal anti-cathepsin D antibody (1:100; sc-6994 from 
Santa Cruz Biotechnology). 
 
2.7.2. Calpain activity 
Calpain activity was measured using the ﬂuorogenic substrate Suc-LY-AMC 
(Calbiochem-Merck KGaA,). An aliquot of lysate with 30 µg of protein was incubated 
with 2.2 mL of the reaction buffer containing 50 mM Tris–HCl pH 7.5, 50 mM NaCl, 5 
mM β-mercaptoethanol, 5 mM CaCl and 50 µM Suc-LY-AMC. The release of 7-amino-
4-methyl-coumarin (AMC) was monitored at an excitation wavelength of 380 nm and 
460 nm of emission on a ﬂuorescence spectrometer. To detect non-speciﬁc protease 
activity, the reaction rate was also measured in the presence of 10 µM Z-2-LLY-FMK 
(Calbiochem-Merck KGaA), a speciﬁc inhibitor of calpain, and the value was 
subtracted from that observed in the absence of the inhibitor. Fluorescence units were 
converted into moles of AMC released using a standard curve obtained with free AMC, 
and calpain activity was expressed in pmol of AMC cleaved per minute per milligram 
of protein. 
 
2.7.3. Hoechst 33258  and propidium iodide staining  
A direct estimation of disrupted plasma membrane CGN was obtained through a 
modiﬁed double-staining technique as described in (Soares et al., 2008) with 
modifications. Brieﬂy, culture medium was discarded, attached cells were washed with 
MLocke 25 buffer, and a stock solution of bisbenzimide (Hoechts 33258 at 10 mg/mL) 
was added to dishes, yielding ﬁnal concentration of 20 µg/mL, during 30 min at 37 ⁰ C. 
To the same dishes, a stock solution of propidium iodide (PI) (10 mg/mL) was added, 
yielding a ﬁnal concentration of 20 µg/mL, during the ﬁnal 5 min of staining. 
Bisbenzimide- (stains genetic material) and PI-stained (indicates disrupted plasma 
membrane cells) cells were examined and photographed, using a Nikon Diaphot 300 
inverted microscope. Filters for PI ﬂuorescence used a 550 nm wavelength, and for 
bisbenzimide, a 420–505 nm wavelength.  
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2.8. Measurement of CGN mitochondrial membrane potential.   
Mitochondrial membrane potential (∆ψm) was monitored in CGN with 
tetramethylrhodamine ethyl ester (TMRE). Cells were stained with TMRE (0.1 µM) and 
0.01% pluronic-F127 at 37 °C. Cell ﬂuorescence images were acquired each 15 seconds 
for 30 min using the Hamamatsu CCD camera with an excitation filter of 470 nm and a 
dichroic mirror DM510 plus an emission filter of 590 nm. Digital images were collected 
at fixed times of exposure with a Hamamatsu Hisca CCD camera, and subsequently 
analyzed with the Argus/Hisca software. At the end, 5 µM Carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), a potent reversible inhibitor of 
mitochondrial oxidative phosphorylation which depolarises mitochondrial membrane 
potential and induces apoptosis, was added to get the intensity of fluorescence after 
complete depolarization of mitochondria.  
 
2.9. Reactive oxygen and nitrogen species  
2.9.1. Intracellular oxidative stress 
2’,7’-Dichlorodihydrofluorescein diacetate (H2DCFDA) (Molecular Probes) 
staining has been used as a measure of intracellular oxidative stress and it was 
performed as described in (Samhan-Arias et al., 2004), with modifications. Briefly, at 9 
DIV, CGCs were switched to MLocke 25 buffer and incubated with 10 µM H2DCFDA. 
Thereafter, cell dishes were placed in the thermostatic plate (37 ⁰C) of a Nikon Diaphot 
epifluorescence microscope, and images were taken each 10 seconds for 20 minutes 
with an excitation filter of 470 nm and a dichroic mirror DM510 plus an emission filter 
of 510 nm. Digital images were collected at fixed times of exposure with a Hamamatsu 
Hisca CCD camera, and subsequently analyzed with the Argus/Hisca software.  
 
2.9.2. Measurement of GSH levels 
GSH measurements were determined using the compound monochlorobimane 
(MCB) as described in (Keelan et al., 2001) with modifications. MCB is a 
nonﬂuorescent bimane, which is freely permeable across the cell membrane. Within the 
cytosol, it is conjugated to GSH to form a ﬂuorescent product. Briefly, cells at 9-10 DIV 
were switched to MLocke 25 buffer and incubated with 10 µM MCB. Cell dishes were 
placed in the thermostatic plate (37 ⁰C) of a Nikon Diaphot epifluorescence microscope, 
and images were taken each 10 seconds for 20 minutes with an excitation filter of 380 
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nm and a dichroic mirror DM510 plus an emission filter of 510 nm. Digital images were 
collected at fixed times of exposure with a Hamamatsu Hisca CCD camera, and 
subsequently analyzed with the Argus/Hisca software.  
 
2.9.3. Nitrotyrosines 
Protein nitrotyrosines were revealed by western blotting after SDS-PAGE of 
lysates as described in 2.6.3, using a polyclonal mouse anti-nitrotyrosine antibody 
(Calbiochem CC22.8C7.3, Calbiochem-Merck KGaA) diluted 1 : 1500 in PBST. 
 
 
2.10. Determination of the intracellular free Ca2+ concentration in 
CGN and cell bioenergetics markers 
2.10.1. Measurement of the cytosolic Ca2+ concentration 
Intracellular calcium concentration ([Ca
2+
]i) was measured basically as indicated 
in previous papers (Gutierrez-Martin et al., 2005; Samhan-Arias et al., 2004). CGC 
were loaded with fura-2 by incubation in DMEM-F12 for 45–60 min with 5 µM fura-2-
acetoxymethyl ester (fura-2 AM) and 0.025% Pluronic-F127 at 37 ºC. Afterwards, CGC 
were washed with MLocke 25 buffer and the culture dish was placed in a thermostatic 
controlled plate (Warner Instrument Co., Hamden, CT, USA) of a Nikon Diaphot 300 
inverted microscope, equipped with an epifluorescence attachment and excitation filter 
wheel. To measure the [Ca
2+
]i, ratio fluorescence images were obtained with excitation 
filters of 340 and 380 nm and a dichroic mirror DM510 and absorption filter (emission 
side) of 510 nm. Digital images were taken with a Hamamatsu ORCA R
2
 CCD camera 
and Lamdba 10–2 filter wheel controller and subsequently analyzed with the HC image 
software.  
 
 
Where R is the average value calculated from the fluorescence ratio (340/380), 
and Rmax and Rmin are the values of ratios (340/380) for the probe fura-2 bound to Ca
2+
 
and the free fura-2 in the CGN (not-bound to Ca
2+), respectively. The parameter β 
represents the average value of the ratio of fluorescence intensities between the free 
fura-2 and fura-2 bound to Ca
2+
 at a wavelength of 380 nm. The dissociation constant 
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(Kd) of this probe for Ca
2+
 is 225 nM, allowing this probe to determine values of [Ca
2+
]i, 
from 20-30 nm to 0.5-1 mM. 
 
2.10.2. Measurements of the effect of rotenone on cytosolic Ca2+ homeostasis in 
CGN 
To test the effect of rotenone in the cytosolic free Ca
2+
 concentration in CGN, 
the intracellular Ca
2+
 concentration has been measured as indicated above. The neurons 
were incubated with fura-2 AM as indicated in 2.10.1 and were subsequently washed 
with MLocke 25 buffer. Then, the ratio images of fluorescence intensities at 340/380 
were obtained as described previously. The basic experimental protocol followed was as 
follows: images of the fluorescence intensity ratio 340/380 were obtained for several 
minutes, then 10 or 15 nM of rotenone was added to the plates and images were 
acquired with short intervals of time until stability signal of the fluorescence intensity 
ratio (340/380) in the soma of CGN. 
 
2.10.3. Effect of flavonoids (kaempferol and epicatechin) and creatine in the 
response of intracellular Ca
2+
 to rotenone 
To investigate the effect of each one of these compounds in the cytosolic Ca
2+
 
response to rotenone; kaempferol, epicatechin or creatine were added at the 
concentrations of 10 µM, 10 µM and 30 mM respectively to the extracellular medium. 
Therafter, ratio images of fluorescence intensities at 340/380 were acquired for several 
minutes before addition of rotenone. To evaluate the possible synergistic effect of 
flavonoids with creatine, each of the flavonoid was incubated with creatine several 
minutes before addition of rotenone. Data acquisition was done as described in 2.10.2. 
 
2.10.4. Treatment of CGN with nifedipine, MK-801, KB-27943 and 
cyclopiazonic acid (CPA) to study their effects in the cytosolic Ca
2+
 
homeostasis alterations observed in response to rotenone 
Treatment with various inhibitors/blockers of the Ca
2+
 transport systems of the 
plasma membrane was accomplished by adding these modulators in the plate after 
having a stable signal of ratio intensities of fluorescence (340/380) in CGN in vitro 
previously incubated with fura-2 AM and washed with MLocke 25. Thereafter, images 
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of fluorescence ratio intensity 340/380 were recorded until the signal reached a new 
stabilization value before addition of rotenone. 
 
2.10.5. Measurements of the effect of rotenone on SOCE activity in CGN  
To evaluate the effect of rotenone in store-operated Ca2+ entry (SOCE) following 
depletion of ER Ca
2+
 stores we have followed a standard protocol, as in (Gruszczynska-
Biegala et al., 2011). Briefly, CGN were incubated with fura-2 AM, and subsequently 
switched to MLocke 25 buffer without Ca
2+
 and the plate was placed in a thermostated 
cell holder. After 5-10 min in the cell holder (to ensure proper temperature 
equilibration), 15 nM rotenone was added to the extracellular medium and images of 
fluorescence ratio intensity 340/380 were recorded during 45 min. Finished the 
incubation time with rotenone, 1 μM thapsigargin (TG) were added to the cell 
suspension and, after 10 min, 1 mM Ca
2+
 was added and the ratio fluorescence images 
were acquired every 10 seconds during 5 min.  
 
2.10.6. Creatine kinase activity 
CK activity in lysates has been measured as described earlier in (Lagoa et al., 
2009). Briefly, a volume of lysate containing 15-25 µg of protein was added to the assay 
buffer composed of: 100 mM Tris–TES buffer pH 7.0, 20 mM glucose, 10 mM 
magnesium acetate, 1 mM adenosine diphosphate, 10 mM adenosine monophosphate, 
0.6 mM oxidized nicotinamide adenine dinucleotide phosphate (NADP
+
), 35 mM 
phosphocreatine, 10 µM diadenosine pentaphosphate, ≥ 1.5 U/mL hexokinase and ≥ 1.5 
U/mL glucose-6-phosphate dehydrogenase. CK activity was calculated from the rate of 
formation of reduced nicotinamide adenine dinucleotide phosphate (NADPH), 
monitored spectrophotometrically at 340 nm, at 37 ºC. CK activity is expressed in µmol 
of phosphocreatine hydrolysed per minute per milligram of protein. 
 
2.10.7. Creatine kinase and phosphorylated AMP-kinase levels 
CK and phosphorylated AMP-kinase levels were monitored by western blotting 
after SDS-PAGE of lysates as described in 2.6.3, using a goat polyclonal anti-CK-B 
antibody (1 : 1000; sc-15157 from Santa Cruz Biotechnology) and a rabbit polyclonal 
anti-phospho-AMPKα (Thr172) antibody (1:500; 2535 from Cell Signaling 
Technology®), respectively. 
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2.11. Statistical analysis 
Results are expressed as means ± standard error (SE). Differences among treatments 
were assessed by analysis of variance (Popova et al., 2004) with Tukey HSD  (Honest 
Significant Difference) multiple comparison test using SigmaStat 3.10 (Systat). 
Signiﬁcant difference was accepted at the p<0.05 levels. All biochemical data were 
conﬁrmed with duplicate measurements of at least experimental triplicates of each 
condition. 
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3.1. Sustained exposure (12 h) of CGN to the neurotoxins 
rotenone and 6-OHDA 
 
3.1.1. Rotenone and 6-OHDA induce cell death in CGN 
 
The cytotoxicity of 2, 5, 10, 15, 20, 30 and 50 nM rotenone as well as the cytotoxic 
effect of 0, 5, 10, 15, 20, 25, 30, 50, 75 and 100 µM 6-OHDA were determined by the 
MTT assay.  
  
 
Figure 3.1: Effect of neurotoxins in CGN viability. (A) Dose-response curve obtained by 
MTT cell viability assay at 2, 5, 10, 15, 20, 30 and 50 nM rotenone for 12 h in CGN. (B) Dose-
response curve obtained by MTT cell viability assay at 0, 5, 10, 15, 20, 25, 30, 50, 75 and 100 
µM 6-OHDA for 24 h in CGN. Independent experiments were repeated three times. Values are 
presented as mean±SEM. *p<0.05 compared to non-treated cells. 
 
Figure 3.1A shows that the cell viability decreased in a dose-dependent manner by 
the treatment with rotenone for 12 hours. Rotenone (5,65±0,51 nM) triggered 50% cell 
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death and the concentration of 5 nM was chosen for subsequent experiments. In Figure 
3.1B is also observed that the cell viability was decreased in a dose-dependent manner 
by the treatment with 6-OHDA for 24 hours. 6-OHDA (12,61±1,05 µM) generated 50% 
of cell death.  
Due to the specificity of 6-OHDA for catecholaminergic neurons and the higher 
toxicity of rotenone in CGN (nM), the latter was chosen for all the subsequent 
experiments. 
 
3.1.2. Creatine, but not kaempferol or epicatechin, protects against rotenone-
induced cell death in CGN 
The effect of creatine, kaempferol and epicatechin on rotenone-induced cell death 
was evaluated.  
Figure 3.2: Effect of creatine on rotenone-induced cell death in CGN. (A) Creatine inhibits 
rotenone-induced cytotoxicity in CGN, treated with 5 nM rotenone for 12 h. Creatine (5, 10, 20 
and 30 mM) was added 1 h before rotenone treatment. (B) Phase contrast images of CGN: 12 h 
with the vehicle (DMSO) is represented as control; 12 h of rotenone incubation is presented as 
rotenone and 12 h of rotenone incubation with a previous (1h) addition of creatine is shown as 
creatine+rotenone. Independent experiments were repeated three times. Values are presented as 
mean±SEM. *p<0.05 compared to cells treated with rotenone only (0 mM Creatine). 
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Figure 3.2 shows that pre-co-treatment with creatine significantly inhibited 
rotenone-induced cell death. Creatine (10-30 mM) increased the cell viability, and 30 
mM creatine improved the cell viability up to the control level (around 100% of 
viability) (p< 0.05). On the other hand, kaempferol and epicatechin, in spite of showing 
no cytotoxicity in the concentrations range 2-20 µM (data not shown), failed to protect 
against rotenone-induced cell death (data not shown). In agreement with the MTT 
results, the morphological observations revealed that creatine significantly reversed the 
cellular damage triggered by rotenone, as shown in Figure 3.2B.  
3.1.2.1. Creatine in combination with epicatechin present a weak synergistic 
effect against rotenone-induced cell death in CGN, while kaempferol 
antagonizes the protective effect of creatine 
Despite the lack of protective effect of the tested flavonoids in rotenone-induced cell 
death, their putative capacity to increase/decrease the protective effect of creatine was 
assessed by MTT. Figure 3.3 shows that it is clear a negative effect of kaempferol, as 
the results pointed out that kaempferol antagonizes the effect of creatine. In the other 
hand, epicatechin, which have no effect by itself in the protection of rotenone-induced 
cell death, elicits a weak increase of the protection of creatine, revealing a weak 
synergistic effect between them on the protection against rotenone-induced neuronal 
death. 
 
 
 
Figure 3.3: Effect of kaempferol and epicatechin on the protective effect of creatine on 
rotenone-induced cell death in CGN. Epicatechin increases the effect of creatine revealing a 
weak synergistic effect, while kaempferol decreased creatine´s effect against rotenone-induced 
cytotoxicity. Independent experiments were repeated three times. Values are presented as 
mean±SEM. All the values are statistically different one of each other (p<0.05). 
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3.1.3. Cathepsin D activation in rotenone-induced cell death in CGN  
Next, we have experimentally assessed the putative pathway/s responsible for the 
neuronal death of CGN caused by rotenone. 
A number of pro-apoptotic stimuli induce the activation of caspase-9, an initiator 
protease that activates execution caspases, such as caspase-3, leading to the 
development of apoptosis (Budihardjo et al., 1999). Many studies have also shown that 
activation of caspase-3 mediates neuronal apoptosis (Hartmann et al., 2000; Porter and 
Janicke, 1999). We investigated by western blotting the presence of active caspase-3 at 
6, 8 and 12h of rotenone incubation, and as observed in Figure 3.4A no statistically 
significant differences were observed with respect to control non-treated CGN. These 
results indicate that death caused by rotenone in these cells does not occur through 
apoptosis, involving caspase-3. The evidence of a non-apoptotic cell death was 
confirmed by staining CGN with PI (PI-stained indicates cells with disrupted plasma 
membrane). As shown in Figure 3.4B, rotenone-induced cell death produced membrane 
disruption, which is verified by the staining with PI of 85.7 % of dyed cells. 
Another cell death pathway observed in PD is necrosis. Proteolysis during necrosis 
does not rely on caspases but on calpains and cathepsins (Zong and Thompson, 2006). 
Since rapid cell death of CGN by necrosis mediated by activation of calpains is 
observed when cytosolic calcium concentration is kept steadily elevated (Choi, 1988; 
Franklin and Johnson, 1992; Garcia-Bereguiain et al., 2008; Gutierrez-Martin et al., 
2005; Orrenius et al., 1989), calpains activity was measured. Calpain activity was 
measured using the ﬂuorogenic substrate Suc-LY-AMC in lysates of 4, 6, 8 and 12h of 
rotenone incubation; however, no statistically significant differences were observed 
between rotenone-treated and control-untreated CGN (data not shown).  
In this scenario and since autophagy has gained relevance in PD studies (Anglade et 
al., 1997; Schapira and Jenner, 2011) and others have shown that CGN death by 
autophagy is mediated by the activation of lysosomal proteases like cathepsin D 
(Maycotte et al.; Uchiyama, 2001), we decided to investigate the levels of the active 
fragment of cathepsin D.  The levels of active cathepsin D were measured by western 
blotting of CGN lysates at 4, 6 and 8 h of rotenone incubation. As it is shown in Figure 
3.4C activation of cathepsin D has been observed at 4h of rotenone incubation. 
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Figure 3.4: Evaluation of cell death pathways in CGN mediated by rotenone. (A) Western 
blot analysis of caspase-3 activated fragment at 6, 8 and 12h of incubation with rotenone; 
revealing no significant differences between control (0 h) and rotenone treated CGN. (B) 
Fluorescence microscopy of CGN; Hoechst dye staining genetic material (nuclei) and 
propidium iodide (PI) dye filling cells with disrupted plasma membrane. (C) Western blotting 
of cathepsin D at 4, 6 and 8 h of rotenone incubation showed an activation of cathepsin D at 4h 
of rotenone incubation. Independent experiments were repeated three times. Values are 
presented as mean±SEM. *p<0.05 compared to non-treated cells, ns: not significant. 
 
 
3.1.4. Creatine completely attenuates rotenone-induced cathepsin D activation   
The capacity of creatine and epicatechin to attenuate the activation of lysosomal 
cathepsin D in the cell death promoted by rotenone in CGN was also evaluated by 
western blotting. Lysates of 4 h of rotenone incubation with a pre-incubation of 1h of 
creatine or epicatechin were analyzed for experimental measurements of active 
fragment of cathepsin D.  The results (Figure 3.5) indicated a complete attenuation of 
cell death by creatine (which restored the control levels of active cathepsin D) while 
epicatechin did not afford a significant reduction of the cathepsin D activation induced 
by rotenone. 
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Figure 3.5: Effect of creatine and epicatechin on rotenone-induced increase of active 
cathepsin D levels in CGN. Independent experiments were repeated three times. Values are 
presented as mean±SEM. Control and creatine (a) as well as rotenone and epicatechin (b) are 
not significantly different between them. 
 
These results are in good agreement with those previously obtained for cell viability 
with the MTT assay (vide 3.1.2). Therefore, the results suggest that autophagy may 
represent a potentially important cell death pathway for the death caused by rotenone in 
CGN, which deserves to be further explored. 
 
3.1.5. Creatine protects against mitochondrial membrane depolarization 
caused by rotenone in CGN 
Rotenone is a well-known blocker of the electron transport chain complex I. Thus, 
inhibition of mitochondrial complex I by rotenone may lead to mitochondrial 
dysfunction such as a decrease in ATP production and mitochondrial membrane 
depolarization (Barrientos and Moraes, 1999; Li et al., 2003; Sherer et al., 2003a).  
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Figure 3.6: Effect of creatine on rotenone-induced mitochondrial depolarization. Neuronal 
cultures were pretreated with 30 mM of creatine for 1 h prior to rotenone treatment for 12 h. 
Mitochondrial membrane potential was monitored by TMRE fluorescence microscopy. (A) 
Average intensity per pixel obtained at a constant fixed time of 10 min or 5 min in fluorescence 
microscopy images acquired with CCD Hamamatsu ORCA R
2
 and HImage software with the 
same light-flash duration (same exposure time) after TMRE addition (left) and after FCCP 
addition (right) respectively. (B) Relative intensity per pixel obtained by subtraction of the 
values of FCCP. Rotenone produced a decrease in TMRE fluorescence intensity (compared to 
control) indicating a significant mitochondrial membrane depolarization. Creatine was able to 
protect against the decrease caused by rotenone on the fluorescence intensity within CGN 
somas, indicating a protective effect against the mitochondrial membrane depolarization 
induced by rotenone. (C) Images of fluorescence microscopy of TMRE-loaded CGN acquired 
with a constant exposure time (flash-lamp time) of 0,2 s. Rotenone-treated neurons exhibited 
lower red ﬂuorescence, revealing loss of mitochondrial membrane potential (∆ψm) caused by 
the decrease in TMRE accumulation within these subcellular organelles. Pretreatment with 
creatine signiﬁcantly protected neurons against rotenone-induced loss of ∆ψm, as demonstrated 
by the maintenance of red ﬂuorescence intensity as well as by the distribution of TMRE 
fluorescence staining within CGN soma. Independent experiments were repeated three times. 
Values are presented as mean±SEM. All the values are statistically different one of each other 
(p<0.05).  
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Therefore, we experimentally assessed the effect of rotenone on ∆ψm in the presence 
or absence of creatine, using TMRE. TMRE is a cell permeant, positively-charged, red-
orange dye that readily accumulates in active mitochondria due to the large negative 
charge of their inner membranes. Indeed, it has been demonstrated that using a large 
number of cell types, depolarized or inactive mitochondria have decreased membrane 
potential and fail to sequester TMRE (Miyamoto et al., 2005; Narendra et al., 2010; 
Natoni et al., 2006). Most of CGN incubated with rotenone 5 nM by 12 h suffered a 
dramatic decrease in ∆ψm, as judged by a decrease in the accumulation of TMRE within 
the cells, shown by the loss of fluorescence intensity signal in microscopy images 
(Figure 3.6C). Pretreatment with creatine signiﬁcantly protected cells against this loss of 
mitochondrial potential, as demonstrated by the maintenance of a high ﬂuorescence 
intensity staining (Figure 3.6B) compared to that obtained for rotenone (at a constant 
fixed time of 10min, to minimize the incidence of other experimental variables like 
exposure to xenon-lamp irradiation and subsequently-induced photobleaching).  
As a positive control FCCP was used. The protonophore FCCP collapses the proton 
gradient across the mitochondrial inner membrane, leading to abolition of the 
mitochondrial potential (Dispersyn et al., 1999). FCCP was added at the end of each 
assay and in cases where the membrane showed no depolarization (control and 
creatine), after FCCP addition red ﬂuorescence intensity was decreased revealing a 
depolarization by FCCP (Figure 3.6A). 
These observations imply that the protective effect of creatine against rotenone-
induced cell death results, in part, from preventing mitochondrial depolarization.  
 
  
3.1.6. Rotenone causes generalized oxidative stress but only a weak nitrosative 
stress in CGN 
PD as well as rotenone-induced brain neurodegeneration has been widely related 
with oxidative stress. Indeed oxidative stress has been pointed as one of the central 
causes of sporadic PD.  
In this study oxidative stress produced by rotenone in CGN was evaluated by three 
different and complementary methodologies: (1) H2DCFDA staining has been used to 
monitor ROS levels causing a generalized intracellular oxidative stress; (2) protein 
nitrotyrosines have been measured in cellular lysates to ascertain the putative 
occurrence of nitrosative stress-mediated by peroxynitrite; and (3) GSH levels were 
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determined in whole CGN cells using the MCB to monitor the putative lowering of the 
intracellular reduction state, as this is the major water soluble antioxidant present in the 
neuronal cytosol.  
H2DCFDA is a cell-permeant dye used as an indicator for ROS in cells. Upon 
cleavage of the acetate groups by intracellular esterases and oxidation, the 
nonfluorescent H2DCFDA is converted to the highly fluorescent 2',7'-
dichlorofluorescein (DCF) which can be detected by fluorescence microscopy with an 
excitation filter of 470 nm and an emission filter of 510 nm. Cells after 12 h of rotenone 
incubation as well as those with an additional pre-icubation by 1h with creatine or 
epicatechin were switched to MLocke 25 buffer and incubated with 10 µM H2DCFDA. 
The intensity of fluorescence within the neuronal somas monitors the conversion of 
H2DCFDA in DCF and can be used as a measurement of ROS produced within the 
cells. However, these measurements need to be done after a short time after H2DCFDA 
addition to the extracellular medium because produced DCF diffuse from the cytosol to 
the extracellular medium with a half time in the minutes-scale range (Samhan-Arias et 
al., 2004). The results of measurements of fluorescence intensities in neuronal somas at 
a fixed time (1 min) after addition of H2DCFDA to the CGN culture are presented in 
Figure 3.7A. The results pointed out a 6-fold increase in DCF compared to the control 
(treated with the vehicle DMSO), revealing a stimulated ROS production in CGN after 
12h incubation with rotenone. Moreover, the results also showed a strong attenuation by 
creatine of the stimulation of ROS production induced by rotenone, noteworthy, higher 
than that afforded by the antioxidant flavonoid epicatechin. 
Protein nitrotyrosines levels in CGN lysates have been used as indicator of the 
nitrosative stress and have been determined using Western blotting. As shown in Figure 
3.7B, 12h incubation of CGN with rotenone elicits only a weak increase of protein 
nitrotyrosines with respect to control (treated with the vehicle DMSO only), 
remarkably, the treatment with (rotenone + creatine) or with (rotenone + epicatechin) 
decreased the levels of protein nitrotyrosines to values lower than those obtained with 
lysates of control CGN. Thus, these results allow concluding that rotenone induces a 
weak nitrosative stress in CGN, which is attenuated by creatine and, in this case, more 
strongly by epicatechin. 
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Figure 3.7: Oxidative stress induced by rotenone in CGN. (A) Intracellular ROS production 
detected by H2DCFDA staining after 12 h of rotenone incubation. (B) Protein nitrotyrosines 
obtained by Western blotting of lysates of CGN treated during 12 h with rotenone. (C) Levels of 
GSH within CGN monitored with MCB after 12 h incubation with rotenone and in control cells. 
(D) Images of fluorescence microscopy of MCB-loaded CGN acquired with a constant exposure 
time (flash-lamp time) of 0,77 s; (a) 1 minute after MCB addition and (b) past, approximately, 
10 minutes when the dye was already conjugated with GSH to form a ﬂuorescent product. 
Independent experiments were repeated three times. Values are presented as mean±SEM. ns: 
not significant, a, b, c and d values are statistically different one of each other (p<0.05). 
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As briefly indicated above GSH is a major component of cellular antioxidant 
defenses. A decrease of GSH levels is currently observed in cells suffering strong 
oxidative stress conditions, due to increased GSH usage, and although part of the GSSG 
generated can be reduced back to GSH, the formation and export of GSH conjugates 
leads to GSH depletion under these conditions. The levels of GSH in CGN after 12h 
incubation with rotenone were determined using the cell permeable dye MCB. MCB is 
a nonﬂuorescent bimane, and within the cytosol it is rapidly conjugated with GSH to 
form a ﬂuorescent product that can be detected by fluorescence microscopy with an 
excitation filter of 380 nm and an emission filter of 510 nm. The intensities of the 
fluorescence of the neuronal soma, at a stable and fixed time after addition of 10 µM 
MCB to the extracellular medium (10 min), are presented in Figures 3.7C and 3.7D, 
revealing that GSH levels are not altered by 12h incubation of CGN with rotenone. 
 
3.1.7. Creatine protects against AMPK activation induced by rotenone in 
CGN 
PD is a disease included within the large number of pathologies related to 
deregulated cellular bioenergetics, nowadays mainly attributed to a functional loss in 
mitochondrial complex I and consequently in the mitochondrial electron transport chain. 
Although it is assumed that this functional loss could compromise cell viability and lead 
to cell death, the functional impairment of cellular enzymes, which can attenuate this 
energetic depletion, namely CK and AMPK, has not been explored in detail. Each one 
of these enzymes is able to supply metabolic energy or to decrease metabolic energy 
waste in neurons suffering the bioenergetics deficit generated by mitochondrial 
functional loss as was mentioned in the Introduction. 
 CK levels were determined by western blotting of CGN lysates. Figure 3.8A 
shows that the levels of CK were not significantly altered after 12 h incubation of CGN 
with rotenone with respect to control (untreated) CGN, neither when incubation of CGN 
was done with rotenone after a pre-incubation of 1 h with creatine or epicatechin. As 
CK is an enzyme sensitive to modulation by ROS/RNS and in particular highly 
sensitive to peroxynitrite (Mihm and Bauer, 2002; Mihm et al., 2002), its activity in the 
CGN lysates cannot be predicted solely on the basis of the protein expression levels. 
Due to this, we also measured the CK activity of CGN lysates (Figure 3.8B), and the 
results showed that 12 h incubation with rotenone did not elicit a significant change of 
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the CK activity. Consistent with these results Western blotting of protein nitrotyrosines 
in CGN lysates did not reveal any significant increase of anti-nitrotyrosine labelling of 
the protein band corresponding to the molecular weight of CK (Figure 3.8A, right 
panel). 
 
 
 
Figure 3.8: CK and AMPK activity in CGN after incubation with rotenone. (A) Western 
blot analysis of CGN lysates did not show significant differences in the level of CK as well as in 
anti-nitrotyrosine labelling of the protein band corresponding to the molecular weight of CK. 
(B) CK activity in CGN lysates after 12 h incubation with rotenone was measured by an 
enzymatic method based on the rate of formation of NADPH, and monitored 
spectrophotometrically at 340 nm, at 37 ºC. No statistically significant differences were 
observed between control CGN and after 12 h incubation with rotenone. (C) Phosphorylated 
AMPK levels detected by western blotting revealed a nearly 10-fold increase in CGN incubated 
12 h with rotenone compared to control. Both, creatine and epicatechin significantly attenuated 
the increase of phosphorylated AMPK levels induced by rotenone. Independent experiments 
were repeated three times. Values are presented as mean±SEM. *p<0.05 compared to non-
treated cells, ns: not significant, a, b, c and d values are statistically different one of each other 
(p<0.05). 
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In contrast, the phosphorylated AMPK levels, determined by Western blotting of 
lysates in the same conditions of CK, were increased nearly 10-fold by 12 h incubation 
with rotenone compared to control (incubated only with the vehicle DMSO) as shown in 
Figure 3.8C. The increase of the phosphorylated AMPK levels caused by rotenone was 
found to be strongly attenuated not only by creatine (approx. 40% reduction) but also by 
epicatechin, which decreased the phosphorylated AMPK levels to values even lower 
than those measured in control CGN lysates.  
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3.2. Acute exposure (30 min) of CGN to rotenone 
 
3.2.1. Creatine attenuates Ca2+ homeostasis deregulation promoted by 
rotenone in CGN 
The maintenance of a steady intracellular and cytosolic Ca
2+
 concentration, i.e. 
calcium homeostasis, can be regarded as a major bioenergetics marker for neuronal 
activity and neuronal survival, as briefly highlighted in the Introduction. 
 
 
Figure 3.9: Creatine affords protection against deregulation of cytosolic Ca
2+
 by rotenone.  
Kinetic traces of the ratio 340/380 of fura 2-AM-loaded CGN after the additions indicated in the 
figure. After loading CGN with fura 2-AM the medium was changed to MLocke 25 and the 
ratio 340/380 measurements were initiated, creatine was added after ≈600 s (where indicated by 
an arrow) and rotenone after ≈1200 s. The results shown are the mean±SEM of experiments 
done by triplicate. 
“Creatine Protects Against Rotenone-induced Cell death of Cerebellar Granule Neurons”          
                                                                                                                          III. Results 
 
51 
 
The ability of rotenone to alter cytosolic Ca
2+
 concentration was evaluated after an 
acute exposure to rotenone during 30 min, aiming to experimentally assess the 
possibility that impairment of intracellular Ca
2+
 homeostasis could be an early event in 
the neurotoxicity of rotenone. As this is a time much shorter than that used for cell 
viability assays we have increased the rotenone concentration in these assays up to 
values double (10 nM) and threefold (15 nM) of the IC50 obtained above for cell 
viability loss after 12 h incubation with rotenone.  
After 45–60 min of incubation with 5 µM fura-2 AM and 0.025% Pluronic-F127 at 
37 ºC in culture medium (DMEM-F12), CGN were washed with MLocke 25 buffer and 
the culture dish was placed in a thermostatic controlled plate. Fluorescence ratio images 
were obtained with excitation filters of 340 and 380 nm during 20 min until the signal 
of the fluorescence intensity ratio (340/380) in the soma of CGN was stabilized. 
Thereafter, rotenone was added and images were acquired during 30 min more at 
intervals of 30 seconds. As observed in Figure 3.9, both 10 and 15 nM rotenone 
concentrations elicit an increase of the ratio 340/380, i.e. of cytosolic Ca
2+
, being 
steeper and larger at the highest rotenone concentration (Figure 3.10A). 
The putative capacity of creatine to prevent the deregulation of cytosolic Ca
2+
 by 
rotenone was experimentally assessed for the two concentrations of rotenone. Creatine 
(30 mM) was added to the culture dish 10 min after stabilization and 10 min before 
rotenone addition. As depicted in Figure 3.9 and numerically represented in Figure 3.10 
creatine significantly reduced the cytosolic Ca
2+
 elevation in both cases, revealing, as 
expected, more protective effect against 10 nM (≈80%) than against 15 nM of rotenone 
(≈40%). Nevertheless, taking into account that the larger the increase of the ratio 
340/380 the better for ascertaining modulatory effects (higher signal to noise ratio), 15 
nM of rotenone was chosen for all the subsequent studies. 
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Figure 3.10: Creatine protection against deregulation of cytosolic Ca
2+
 by rotenone.  (A) 
Ratio (340/380) increase after addition of rotenone (absolute values) obtained from the analysis 
of the kinetic traces shown in the Figure 3.9. (B) Initial slope of the ratio (340/380) increase 
after addition of rotenone expressed as percentage of the values obtained for the addition of only 
rotenone. *p<0.05 compared to cells treated only with rotenone. 
 
 
 
3.2.2. Epicatechin, but not kaempferol, attenuated Ca2+ homeostasis 
deregulation promoted by rotenone, and, both flavonoids antagonized 
the protective effect of creatine 
The possibility that the antioxidant flavonoids epicatechin and kaempferol could act 
as protectors against rotenone-induced Ca
2+
 homeostasis deregulation has also been 
evaluated, as well as the capacity of these two flavonoids to increase/decrease the effect 
of creatine.  
The procedure was the same used for creatine, but in this case we have done co-
incubation of creatine and each flavonoid to evaluate their putative 
synergistic/antagonistic effects. As it can be seen in Figure 3.12, like creatine, 
epicatechin was also able to significantly protect (p<0.05) against rotenone-induced 
Ca
2+
 homeostasis deregulation. However, when these two compounds (creatine and 
epicatechin) were added together there were no indications of synergistic effects, but on 
the contrary epicatechin showed an antagonistic effect with creatine, as the kinetic 
traces of the ratio 340/380 did not show a statistically significant reduction of the ratio 
increase with respect to those obtained after incubation with only rotenone (Figures 3.11 
and 3.12). Similar results were found in the case of co-incubation of creatine with 
kaempferol (Figures 3.11 and 3.12). 
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Figure 3.11: Effects of creatine, epicatechin and kaempferol (alone and in combination) on 
deregulation of cytosolic Ca
2+
 by rotenone.  Kinetic traces of the ratio 340/380 of fura 2-AM-
loaded CGN after the additions indicated in the figure. After loading CGN with fura 2-AM the 
medium was changed to MLocke 25 and the ratio 340/380 measurements were initiated. 
Creatine or epicatechin or kaempferol as well as creatine with epicatechin and creatine with 
kaempferol were added after ≈600 s (where indicated by an arrow) and rotenone after ≈1200 s. 
The results shown are the mean±SEM of experiments done by triplicate. 
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Figure 3.12: Creatine and epicatechin afford partial protection against deregulation of 
cytosolic Ca
2+
 by rotenone.  (A) Ratio (340/380) increase after addition of rotenone (absolute 
values) obtained from the analysis of the kinetic traces shown in the Figure 3.11. (B) Initial 
slope of the ratio (340/380) increase after addition of rotenone expressed as percentage of the 
values obtained for the addition of only rotenone. *p<0.05 compared to cells treated only with 
rotenone. 
 
 
3.2.3. Rotenone leads to Ca2+ homeostasis deregulation through functional 
alterations of several Ca
2+
 transport systems of the plasma membrane 
and ER 
 
The deregulation of the steady cytosolic Ca
2+
 concentration by rotenone indicated 
above prompted us to develop experimental studies aiming to identify the putative 
impairment of the major Ca
2+
 transport systems involved in the control of CGN 
cytosolic Ca
2+
 homeostasis.   
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Figure 3.13: Effects of inhibitors of the major Ca
2+
 transport systems controlling the 
cytosolic Ca
2+
 homeostasis in CGN on Ca
2+ 
deregulation caused by rotenone.  Kinetic traces 
of the ratio 340/380 of fura 2-AM-loaded CGN after the additions indicated in the figure. After 
loading CGN with fura 2-AM the medium was changed to MLocke 25 and the ratio 340/380 
measurements were initiated. MK-801 or CPA were added after ≈600 s and rotenone after 
≈1200 s (where indicated by the arrows). The results shown are the mean±SEM of experiments 
done by triplicate. The kinetic traces obtained for nifedipine are almost identical to that of MK-
801 and the kinetic trace obtained for cyclopiazonic acid (CPA) is almost identical to the 
averaged trace obtained for KB-R7943.  
 
As briefly commented in the introduction, cytosolic free Ca
2+
 is approximately 
10,000-fold lower than the free Ca
2+
 concentration in the extracellular space.  Therefore, 
to maintain Ca
2+
 homeostasis, Ca
2+
 entering neurons must be pumped back across the 
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plasma membrane concentration gradient and/or rapidly sequestered by intracellular 
organelles (largely by ER and mitochondria). In mature CGN in vitro the plasma 
membrane Ca
2+
 transport systems have the highest impact in controlling the 
homeostasis of cytosolic Ca
2+
, being in this regard L-VOCC and NMDA receptors the 
most relevant Ca
2+
 entry systems and PMCA and NCX the most relevant systems for 
extrusion of Ca
2+
 from the cytosol (Gutierrez-Merino, 2008). On these grounds, we 
started this study using inhibitors/blockers of these Ca
2+
 transport systems of the plasma 
membrane. More precisely, nifedipine (2 µM) has been used as L-VOCC blocker, MK-
801 (10 µM) as a NMDA antagonist and KB-R7943 (5 µM) as inhibitor of NCX. In 
addition, we have also experimentally assessed the putative impairment of the Ca
2+
-
ATPase of sarco-endoplasmic reticulum (SERCA) using the specific inhibitor CPA (50 
µM). These compounds were added to the culture dish and cytosolic Ca2+ measurements 
were performed as indicated previously. Each one of the tested inhibitors was added to 
the culture dish 10 min after stabilization of the ratio 340/380 measurements and 10 min 
before the addition of rotenone. Fluorescence ratio images were obtained with excitation 
filters of 340 and 380 nm with a time interval of 30 seconds. The results obtained 
demonstrated that nifedipine and MK-801 elicit a partial and statistically significant 
attenuation of the deregulation of calcium homeostasis caused by rotenone (Figure 
3.14), therefore, indicating functional impairment of L-VOCC and NMDA by rotenone.  
 
 
Figure 3.14: Effect of inhibitors of the major Ca
2+
 transport systems controlling the 
cytosolic Ca
2+
 homeostasis in CGN on Ca
2+ 
deregulation caused by rotenone.  Values 
presented are the initial slope of ratio (340/380) increase expressed as percentage of the values 
obtained for the addition of only rotenone. The results shown are the mean±SEM of 
experiments done by triplicate. *p<0.05 compared to CGN treated only with rotenone. 
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During last years many studies have pointed out the implication of SOCE in cellular 
responses to stress conditions mediated by Ca
2+
 deregulation, as briefly summarized in 
the introduction of this work. Therefore, we have assessed the putative functional 
impairment of SOCE on the cytosolic Ca
2+
 deregulation induced by rotenone in CGN.   
 
 
Figure 3.15: Rotenone induces functional impairment of SOCE in CGN. Kinetic traces of 
the ratio 340/380 of fura 2-AM-loaded CGN after the additions indicated in the figure. After 
loading CGN with fura 2-AM the medium was changed to MLocke 25 and the ratio 340/380 
measurements were initiated. (A) CGN were treated with 1 μM thapsigargin (TG)  in MLocke 
25 without added Ca
2+
 in control conditions (45 min in MLocke 25 without added Ca
2+
 and in 
the absence of rotenone), and 600 s later 1 mM Ca
2+
 was added to the extracellular medium. (B) 
After 45 min of incubation with rotenone CGN were treated with 1 μM TG in MLocke 25 
without added Ca
2+
, and 600 s later 1 mM Ca
2+
 was added to the extracellular medium. The 
results shown are the mean±SEM of experiments done by triplicate. 
 
 
After loading CGN with fura 2-AM (45–60 min of incubation with 5 µM fura-2 AM 
and 0.025% Pluronic-F127 at 37 ºC) in culture medium (DMEM-F12), CGN were 
changed to a MLocke 25 buffer without Ca
2+
 (0 mM Ca
2+
). Fluorescence ratio images 
were obtained as indicated in the Materials and methods during 45 min. As shown by 
the results of the Figure 4.15, addition of 1 µM TG to CGN pre-incubated 45 min with 
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15 nM rotenone induced an increase of the ratio 340/380 which is approximately three-
fold higher than the increase observed with control (untreated) CGN. This result point 
out that incubation with rotenone results in Ca
2+
 overload of ER. Later addition of 1 
mM Ca
2+
 to the extracellular medium, after Ca
2+
 depletion of ER stores, should lead to 
opening SOCE inducing a further raise of the ratio 340/380 values as shown in the case 
of control (untreated) CGN (Figure 3.15A). Noteworthy, this response is largely 
attenuated in CGN incubated with rotenone (Figure 3.15B), pointing out that the 
treatment with rotenone has led to an almost complete blockade of the opening of 
plasma membrane Ca
2+
 channels responsible of SOCE. These results strongly support 
that functional impairment of SOCE also mediates rotenone-induced deregulation of 
cytosolic calcium homeostasis in CGN. 
 
 
 
3.2.4. Acute (30 min) exposure of CGN to rotenone did not lead to oxidative 
stress neither to mitochondrial membrane depolarization 
As we have shown that rotenone triggered an oxidative stress and a mitochondrial 
membrane depolarization in CGN after 12 h incubation, we wanted to ascertain whether 
these are early events or events taking place at a later stage than cytosolic Ca
2+
 
deregulation. To this end, intracellular oxidative stress was measured using H2DCFDA 
staining in living cells and protein nitrotyrosines levels in CGN lysates as indicated 
before in this work. The experiments were performed as described for the analysis of 
these experimental parameters after 12 h incubation with rotenone (see section 3.1.6), 
except that in this case the incubation with rotenone was only 30 min. As shown in 
Figure 3.16A, the oxidation of H2DCFDA did not increase after incubation of 30 min 
with rotenone with respect to that measured for control (untreated) CGN because no 
increase of the fluorescence of DCF at a fixed time (1 min) is observed, on the contrary, 
it is significantly lowered. Thus, 30 min of incubation with rotenone are not enough to 
trigger an enhanced production of ROS in CGN. Regarding nitrosative stress, the results 
obtained by western blotting of lysates of CGN with 1h of incubation with rotenone 
showed no statistically significant differences in protein nitrotyrosine levels between 
rotenone-treated and control (untreated CGN lysates), indicating that an acute exposure 
to rotenone does not stimulate RNS production in CGN.  
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Figure 3.16: Incubation of CGN with rotenone for 30-60 min does not increase oxidative 
stress in CGN. (A) Intracellular ROS production detected by CGN stained with H2DCFDA is 
not increased after 30 min incubation with rotenone. (B) Protein nitrotyrosines levels revealed 
by western blotting of CGN lysates do not increase after 1h incubation with rotenone. The 
results shown are the mean±SEM of experiments done by triplicate. *p<0.05 compared to non-
treated cells, ns: not significant. 
 
 
The effect of rotenone ∆ψm was assessed using TMRE as in 3.1.5. The cells 
incubated with 15 nM of rotenone during 30 min do not seem to have a decrease in 
∆ψm, as indicated by the maintenance of the accumulation of TMRE in cells (red 
ﬂuorescence) (Figure 3.17B) and also by the preservation of intensity (Figure 3.17A) 
compared to that obtained for control. Thus, the results suggest that ∆ψm is not 
significantly affected by an acute exposure of CGN to rotenone.  
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Figure 3.17: Effect of 30 min incubation with rotenone on the mitochondrial membrane 
potential (∆ψm) of CGN. CGN were incubated with 15 nM of rotenone for 30 min. ∆ψm was 
monitored with the TMRE assay. (A) Average intensity per pixel obtained at a fixed time after 
addition of TMRE (10 min) from the analysis of quantitative fluorescence microscopy images 
acquired with the Hamamatsu ORCA R
2
 CCD and HCImage software. Incubation with rotenone 
did not afford a statistically significant decrease in TMRE intensity (compared to control). (B) 
Images of fluorescence microscopy. Rotenone-treated neurons maintained the bright red 
ﬂuorescence indicative of active mitochondria. Independent experiments were repeated three 
times. The results shown are the mean±SEM of experiments done by triplicate. ns: not 
significant. 
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Although there is lack of certainty on the pathophysiology of neurodegenerative 
mechanisms underlying PD, it is well accepted that energy depletion, oxidative stress 
and mitochondrial dysfunctions are major factors associated with this disorder (Dexter 
et al., 1994; Jenner and Olanow, 1998; Schapira and Jenner, 2011). Furthermore, as 
have been highlighted in the Introduction, PD pathology is not restricted to DA 
degeneration. The application during the last years of medical techniques, such as TMS, 
SPECT, PET and fMRI has revealed functional anomalies of the cerebellum in PD and 
Parkinsonism patients (Brockmann et al., 2012; Cao et al., 2011; Kimura et al., 2011; 
Koch et al., 2009; Ni et al., 2010; Wu et al., 2009a; Wu et al., 2009b). Moreover, no 
single cellular and animal model to date has been able to recapitulate all the 
pathological features of PD, although the neurotoxic animal models of PD have 
contributed much to our understanding on human PD (Cannon and Greenamyre, 2010). 
Three neurotoxins, 6-OHDA, MPTP and rotenone, are the most successful agents so far 
to mimic Parkinsonism in vitro and in vivo (Beal, 2001). 
Bearing this in mind, we have used a CGN/rotenone model which is a widely used 
model for the study of cellular and molecular correlates of cell death and 
neurodegeneration/neuroprotection (Contestabile, 2002). 
Our results revealed a strong protection by the ergonenic molecule creatine against 
CGN death promoted by rotenone, indicating an energetic failure mediated by rotenone 
in these neurons, since creatine have been widely reported as an energetic compound 
(Andreassen et al., 2001a; Bender et al., 2008a; Pan and Takahashi, 2007; Wyss and 
Schulze, 2002). The mentioned energetic failure was further supported by the ability of 
creatine to prevent the mitochondrial depolarization triggered by rotenone, a target 
event of a cellular energetic unbalance.  
Despite the many reports in the bibliography suggesting an involvement of oxidative 
stress as a primary event in PD, the flavonoid antioxidants kaempferol and epicatechin 
failed to afford protection of CGN against rotenone neurotoxicity. On the contrary, in 
this work we have found that kaempferol potentiates de cytotoxic effect exerted by 
rotenone. This potentiation of rotenone cytotoxicity by kaempferol could be accounted 
by the inhibition by kaempferol of mitochondrial complex I activity, a novel 
experimental finding reported in a previous work of this laboratory (Lagoa et al., 2011), 
because as shown in this publication 10 µM kaempferol produced approximately 30% 
inhibition of the activity of complex I. Indeed, as briefly summarized in the 
Introduction, inhibition by rotenone of mitochondrial complex I is accepted as the 
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primary cause of rotenone cytotoxicity. These results are also in good agreement with 
the ability of kaempferol to antagonize the protection afforded by creatine against 
rotenone.  On the other hand, in the same study (Lagoa et al., 2011) 10 µM epicatechin 
showed a very weak effect on complex I activity. Consistent with this result, in this 
work we show that epicatechin did not antagonize the protection afforded by creatine 
against rotenone cytotoxicity, on the contrary, epicatechin has been found to elicit a 
weak increase of the protection effect of creatine. Thus, our results led to the conclusion 
that different flavonoids can be harmful or beneficial in PD therapy depending on their 
cellular actions as bioactive molecules, not only on their chemical antioxidant 
properties.  
In addition, direct measurements of ROS production and protein nitrotyrosines 
levels point out that oxidative stress is not an early event in the rotenone cytotoxicity to 
CGN, because of the absence of oxidative and nitrosative stresses after an acute 
exposure (30 min) to rotenone. However, after 12 h an increased production of ROS 
was observed, as well as a weak nitrosative stress confirming that cellular oxidative 
stress is a delayed or later event in CGN death induced by rotenone. Noteworthy, 
creatine had a strongest effect against ROS overproduction induced by the treatment of 
CGN with rotenone than the flavonoid antioxidant epicatechin. This result is in good 
agreement with results reported by others showing that creatine have direct chemical 
antioxidant properties as it can act as a scavenger of free radical species (Lawler et al., 
2002) and also indirect antioxidant capacities in cells and tissues (Sestili et al., 2011). 
Our results show that rotenone promoted cellular death in CGN does not elicit a 
statistically significant activation of caspase-3, the major execution caspase in apoptotic 
neuronal death, nor of the calpains, the calcium-dependent proteases strongly activated 
in excitotoxicity-induced neuronal death. On the contrary, our results show  that the 
levels of cathepsin D were elevated, a lysosomal protease that has been shown to 
degrade the excess of α-syn observed in DA cells during development of PD (Cullen et 
al., 2009), suggesting autophagy as the likely major pathway for rotenone-induced 
cellular death in CGN. Noteworthy, up-regulation of cathepsin D has been recently 
reported in the caudate nucleus of primates with experimental parkinsonism 
(Yelamanchili et al., 2011). Our results are also on line with those reported by others 
showing that rotenone induces autophagy neuronal death in SH-SY5Y cells (Filomeni et 
al., 2012). Let us note that a simple hypothesis would be that the energetic depletion 
induced by rotenone could drive to an energetic failure of the lysosomal proton pump, 
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which is in charge of maintaining an acidic environment within the lysosomal 
compartment, and subsequent lysosomal destabilization, i.e. autophagy. However, we 
are aware that further studies using other markers of lysosomal integrity and function 
are needed to gain a deeper knowledge of the leading molecular mechanisms involved 
in cell death pathway induced by rotenone, but due to the extent of these studies these 
are out of the scope of this Master thesis.  
As our results clearly point out that a bioenergetics crisis is at the onset of the CGN 
death induced by rotenone, and this is on line with the major role of impaired 
bioenergetics in PD suggested by other authors (see above), we decided to 
experimentally assess whether the functional state of the main bioenergetics 
compensatory systems CK and AMPK is preserved or altered. As observed in Figure 
3.8, the protein levels and activity of CK where unchanged. Moreover, it has been 
shown that CK is highly sensitive to an increase of nitroxidative stress in the brain and 
heart, which leads to a signiﬁcant inhibition of this enzyme (Aksenov et al., 2000; 
Mihm and Bauer, 2002). Therefore, the maintenance of the activity of CK is fully 
consistent with other experimental observations done in this work, namely, that 
rotenone induced at most a weak nitroxidative environment in CGN and also the 
beneficial effect of creatine supplementation to revert the neurotoxicity promoted by 
rotenone. We wish to note that if CK was nitrosylated, the system should be irreversible 
inactivated and the supplementation with creatine would be expected to be ineffective.  
The other bioenergetics compensatory system studied herein, AMPK, was strongly 
affected by rotenone, as shown by the approx. 10-fold increase of its phosphorylated 
active form compared to control. The simplest hypothesis to account for this fact is that 
AMPK is sensing the rise of AMP levels in parallel to falling ATP levels accompanying 
rotenone-induced bioenergetics depletion in CGN, but it is to be noted that a mild drop 
of the intracellular redox status (rise of the ratio NAD
+
/NADH) may also contribute to 
the activation of AMPK (Rafaeloff-Phail et al., 2004). Despite the need for further 
experimental work to settle the molecular mechanisms underlying this activation, the 
reduction of AMPK active levels in the conditions that protect against rotenone-induced 
death, i.e. in the presence of creatine and epicatechin, indicates that activation of AMPK 
is a good marker of the rotenone-signaling pathway leading to CGN death. In a 
metaphorical sense we could say for CGN that “in bioenergetics crisis AMPK activity is 
largely stimulated (rotenone presence) while in time of bioenergetics prosperity AMPK 
remains largely inactive (creatine and epicatechin presence)”. Indeed, it is well known 
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that AMPK can be seen as a ‘fuel gauge’ to monitor cellular energy status in other 
mammalian cells, see e.g. (Viollet et al., 2007).  
In this scenario of energetic failure we look forward to understand the effect of 
rotenone in Ca
2+
 homeostasis, since cytosolic Ca
2+
 concentration can be regarded as a 
major bioenergetics marker for neuronal activity and survival.  
The results revealed a sustained and early (observed within 30 min) increase in 
cytosolic Ca
2+
 concentration after acute rotenone treatment, which should lead to an 
increase in the activity of CGN in culture. This conclusion is in good agreement with 
recent studies, which indicate a correlation between PD and increased functional 
connectivity/activity in cerebellum (Cao et al., 2011; Wu et al., 2009a; Wu et al., 
2009b). The experiments performed with TG, a drug used for emptying the Ca
2+
 store of 
the ER (Spohn et al., 2010), indicate that acute treatment with rotenone promotes a Ca
2+
 
overloading of ER in mature CGN, as revealed by the larger increase of Ca
2+
 after TG 
addition in rotenone-treated cells than in control cells (Figure 3.15). This result is 
consistent with the expected result for cells working with a cytosolic Ca
2+ 
concentration 
steadily elevated. In addition, the increased cytosolic Ca
2+
 concentration has been 
reported to contribute to the development of glutamate-induced excitotoxicity that in 
turn induces neurodegeneration (Frandsen and Schousboe, 1993; Li et al., 2004). The 
results obtained in this work unravel an effect of acute rotenone treatment in the 
function of NMDA receptor, namely, rotenone-induced a sustained stimulation of Ca
2+
 
entry through NMDA receptors in CGN in culture. The simplest possibly is that 
rotenone stimulated basal glutamate release, a novel hypothesis that deserves to be 
experimentally assessed by direct measurements of glutamate secretion in our working 
conditions. In addition, the results obtained in this work have shown that acute rotenone 
treatment stimulated also Ca
2+
 entry through L-VOCC. Very recently, in a work of our 
laboratory it has been demonstrated that L-VOCC and NMDA receptors are vicinal 
proteins in the plasma membrane of mature CGN (Marques-da-Silva and Gutierrez-
Merino, 2012). As noted in Marques-da-Silva (Marques-da-Silva, 2012) a functional 
consequence of this proximity is that activation of L-VOCC should evoke L-glutamate 
release near the NMDA receptors, thereby, potentiating its effect on the receptors due to 
the generated gradient of L-glutamate concentration. Experiments addressing the 
demonstration of these points are programmed in our laboratory, as these conclusions 
have been achieved near the end of this Master work. Noteworthy, one of the most 
relevant Ca
2+
 channels involved in the pacemaking activity of DA neurons is the L-
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VOCC subtype Cav1.3 (Chan et al., 2007) and as L-VOCC are modulated by 
phosphorylation by protein kinase A and also by PK-CaM (Catterall, 2000; Grueter et 
al., 2006) an impaired bioenergetics should be expected to lead to an altered activity of 
these Ca
2+
 channels. Moreover, it is now accepted that Ca
2+
 entry through plasma 
membrane Cav1.3 Ca
2+
 channels during an excessive activity could be involved in PD 
pathology (Surmeier et al., 2011a).  
Finally but not less important, CGN exposed to an acute treatment with 15 nM 
rotenone for 45 min has a strong downregulation of their SOCE response with respect to 
control (untreated) CGN. Indeed, once the ER stores are depleted in Ca
2+
 by addition of 
TG, rotenone-treated CGN have lost almost completely their ability to elevate cytosolic 
Ca
2+
 after Ca
2+
 addition to the experimental medium (without Ca
2+
 until that moment), 
in contrast to control CGN. These results are in line with those published by Selvaraj et 
al on April of this year (Selvaraj et al., 2012). For the first time, Selvaraj et al. 
demonstrated that in a mouse neurotoxin-based model of PD, reduced Ca
2+
 influx 
through transient receptor potential C1 (TRPC-1) channels in the plasma membrane of 
DA neurons triggers a cell death-inducing ER stress response. These results received a 
special editorial comment by Mattson MP (Mattson, 2012), aiming to highlight the 
relevance of Ca
2+
 homeostasis in PD, somehow overlooked until now. It is to be 
recalled here that these channels and in particular the isoforms TRPC-3 and -6 have 
been also involved in neuronal survival of CGN (Jia et al., 2007). 
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 Creatine protects against the loss of cellular viability triggered by rotenone in 
CGN, whereas the flavonoids kaempferol and epicatechin do not elicit a 
significant protection.  
 
 The strong stimulation of AMP-kinase also supports that the toxicity triggered 
by rotenone in CGN is largely due to an energetic failure, being oxidative 
stress caused by the rise of ROS a later event. The molecular mechanism 
of rotenone-induced AMP-kinase activation needs further investigation 
to be established.  
 
 
 Kaempferol antagonizes the neuroprotection afforded by creatine, suggesting 
avoiding the consumption of foods or infusions with high content in this 
flavonoid in the therapeutics of PD. 
 
 The cellular death caused by rotenone in CGN correlated with the activation of 
the lysosomal protease cathepsin D, while caspase-3 and calpains 
activation are negligible, suggesting the prevalence of an autophagic 
pathway involving lysosomal destabilization. Further studies are needed 
to experimentally ascertain this hypothesis. 
 
 Rotenone induces an early deregulation of cytosolic calcium homeostasis. Our 
results show that exposure to rotenone induced a sustained elevation of 
cytosolic calcium in CGN, mediated by calcium entry through L-VOCC 
channels and NMDA receptors. Rotenone also promoted calcium 
overloading of the ER and a down-regulated SOCE response in CGN.  
 
 Up-regulation of cathepsin D, deregulation of calcium homeostasis and down-
regulation of SOCE are recently recognized markers of PD 
neurodegeneration. Therefore, the results obtained in this work further 
validate the use of primary CGN in culture as a cellular model for 
studying the molecular mechanisms underlying the neurodegeneration of 
cerebellum elicited in PD. 
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